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This thesis describes a possible alternative 
isoprenoid pathway in bacteria by considering some 
previously unpublished feeding studies in the context of 
the related background literature. 
Three synthetic routes to 2,4-dihydroxy-4-methyltetra-
hydropyran (63) and three synthetic strategies towards the 
synthesis of 2carboxy-2 , 4-dihydroxy4-methyitetrahydro-
pyran (66) are discussed. These compounds are considered 
as potential intermediates in the proposed alternative 
bacterial isoprenoid pathway. Labelled synthesis of (63) 
and structural analysis of (63) and 4-hydroxy-2-methoxy-4-
methyltetrahydropyran (99) by proton nmr are also 
described. 
Feeding studies including the 13C isotopically 
labelled tetrahydropyrans (63) and (99) are described and 
a revised interpretation of all of the feeding studies 
considered. 
HNGC0A synthase is assayed in Rh. capsulata after a 
description of its assay in bakers yeast. 
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Terpenoids are the most taxonomically widespread and 
structurally diverse group of natural products known'-4 . 
They are characterised by a carbon framework consisting of 
multiples of the regular five carbon (CO 
2-methylbuta-1,3-diene (1) or "isoprene" fragment which is 
often obtained on pyrolysis of C10 compounds. 	The 
"structural isoprene rule's of Wallach and Robinson 3 
originally defined isoprenoids as (C 5) compounds produced 
by the successive linear head to tail condensation of 
isoprene units. 	Ruzicka 5 later amended this to the 
"biogenetic isoprene rule" to take into account 
isoprenoids derived from (C5) compounds in a 
mechanistically reasonable way, i.e. cyclisation or 
rearrangement. 
Classification of isoprenoids is based on the term 
terpene, which was originally introduced to describe 
compounds containing ten carbons. 	This classification 
divides isoprenoids into: heiniterpenes (C 5); monoterpenes 
(C10), e.g. camphor (2); menthol (3); sesquiterpenes 
(C15), e.g. y-bisabolene (4); diterpenes (C20 ), e.g. 
vitamin A (5); gibberellin A 3 (6); sesterterpenes (C25); 
triterpenes (C30 ), e.g. cholesterol (7); carotenoids 
(C40), e.g. 0-carotene (8) and molecules of mixed 
biogenesis e.g. ubiquinone (9) and quinine (10) which are 
2 
familiar to us as natural fragrances, human and plant 
hormones and drugs and flavourings. 
















2. EUKARYOTIC ISOPRENOID BIOSYNTHESIS 
For many years a number of C. acids and aldehydes 
(e.g. tiglic acid (11) and angelic acid (12)) were 
considered as possible precursors of the isoprenoids as 
isoprene (1) is not a naturally occurring compound. The 
first major advance came when Folkers68 (1956) discovered 
that mevalonic acid (16) is a naturally occurring growth 
factor of certain strains of lactobacilli, and 
Tavormina 9 ' 1 ° found that it is an extremely efficient 
precursor of cholesterol (7).. Since then the biosynthesis 
of mevalonic acid (16), its conversion into the biological 
C. unit and elaboration into the isoprenoids has been 
completely elucidated due mainly to the pioneering work of 
Bloch' 1 1 3, Lynen' 4' 6, Cornforth' ?2 0 and Popjak2 1 
CO2H 	 (12)< 
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The sequence begins (Scheme 1) with a condensation of 
two molecules of acetyl-CoA (13) catalysed by the enzyme 
thiolase. In the next step, 3-hydroxy-3-methy1g1utary1-
00A (HNGC0A) synthase2225 catalyses the condensation of a 
third acetyl-00A (13) with acetoacetyl-00A (14) to yield 
HMGC0A (15). This product is reduced to mevalonic acid 
(16) by HMGC0A reductase2628. 	Mevalonic kinase29 and 
phosphomevalonate kinase then sequentially catalyse the 
double phosphorylation of mevalonic acid (16) to give 




decarboxylase3 catalysed trans 
elimination of carbon dioxide and phosphate gives 
isopentenyl pyrophosphate (IPP) (19). 	This is then 
isomerised to dimethylallyl pyrophosphate (DMAPP) (20) in 
the presence of isopentenyl pyrophosphate isomerase3133. 
Addition of a proton from the medium onto the re,re face 
of IPP is concerted with. the abstraction of the pro (R) 








These two activated C5 units (IPP and DMAPP) are the 
biological equivalent of isoprene and condense in the 
presence of transferases in a head to tail manner (Figure 
2) to produce geranyl pyrophosphate (GPP) (C, 0), farnesyl 
pyrophosphate (FPP) (C1 5) and the other (C5) n  homologues. 
It is not certain whether this overall syn process is an 
SN]. or SN2 type mechanism. 	A consecutive anti-1,2- 
addition anti-1,2-elimination sequence and a carbocation 
intermediate have both been suggested'. 
All of the enzymes mentioned have been purified and 
characterised from yeasts and mammalian livers. 	Of 
particular importance is HNGC0A reductase as it has been 
found to be the major regulator of cholesterol 
biosynthesis4. 	The phosphorylation scheme for its 
regulation is shown in Figure 3. 
HMGCoA reductase kinase kinase catalyses the 
phosphorylation and activation of HNGC0A reductase kinase. 
This latter kinase phosphorylates HMGC0A reductase which 
results in its inactivation. The effects are reversed by 
the action of HNGC0A reductase kinase phosphatase and 
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ADP 
HMGCoA REDUCTASE (active) 	HMGCoA REDUCTASE-P (inactive) 
Pi 
HMGCoA REDUCTASE PHOSPELASE 
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FIGURE 3 
More important is the clinical control of HMGC0A 
reductase. It has long been recognised that a correlation 
exists between high serum cholesterol (7) levels and 
cardiovascular disease and that most of the serum 
cholesterol (7) is made in the liver 4. Thus, since HMGC0A 
reductase catalyses the key regulatory step in its 
synthesis it seems logical to search for a drug that would 
inactivate it. One such drug mevinolinic acid (21) has 
been found to inhibit HMGC0A• reductase and reduce plasma 





3. ALTERNATIVE EUKARYOTIC PATHWAYS 
Despite the generally accepted ubiquity of the 
acetoacetate pathway (Scheme 1), a number of anomalous 
incorporations of isotopically enriched precursors into. 
eukaryotic isoprenoids have been reported3 438 
It has been known for many years that HNGC0A (15) is 
also formed in the degradation of leucine (22) (Scheme 2) 
and because of this it has long been considered. that 
leucine (22) might be directly involved in isoprenoid 
biosynthesis20. However, although radioactivity from 14C 
leucine has been incorporated into various terpenoids in 
animals, plants and micro organisms it. has been shown 
recently that leucine is not directly involved in 
the biosynthesis of paniculide B (32) in the plant 
Andrographis paniculata34. 
(32) 
Incorporation patterns from [2-13C] and [3 1 C] 
leucine feeding studies indicate that leucine is broken 
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Leucine catabolism has also been invoked for the 
"shunt pathway" of mevalonate metabolism 35 (Scheme 2). 
The existence of this pathway is based on identification 
of 14C labelled prenoates (e.g. 3,3-diniethylacrylate (31)) 
in tissues from rats injected with 14C labelled mevalonate 
(16). Further support came from the distributions of 1 
in 3-hydroxybutyrates (28) formed by diabetic rats 
injected with various 'C labelled mevalonates35 . 
The labelling patterns show that:- C-1 of mevalonate 
(16) is lost in the formation of acetoacetate (27), C-2, 3 
and 6 are present in acetoacetate (27) and C-5 becomes C-i 
and 3 of acetoacetate (27) in keeping with the 
condensation of acetyl-00A (13) units formed from 
mevalonate (16). 	It is argued that this "mevalonate 
recycling" occurs in the mitochondria and that it is the 
extraniitochondrial pool of HMGC0A (15) that is the 
precursor of mevalonate (16)35 . 
The role of malonate36 in isoprenoid biosynthesis has 
been the subject of experimentation for many years and 
there is evidence to support an alternative pathway to 
HMGC0A (15) via malonyl C0A (33) (Scheme 3). 	The key 
difference between this alternative' pathway and the 
"acetoacetate" pathway (Scheme 1) is the way in which the 
acetoacetyl thioester is formed. 	In the "acetoacetate" 
pathway, acetoacetyl-00A (14) is formed by the 
condensation of two molecules of acetyl-00A (13). 
13 
MALONATE PATHWAY 
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SCHEME 3 
This reaction, which has an equilibrium constant (1.6 x 
10 	at pH 7.0) that is clearly in favour of thiolysis, is 
used to produce acetyl-CoA (13) in the oxidation of fatty 
acids. In the malonate pathway the acetoacetyl moiety is 
formed bound to protein, from a protein bound acetate 
molecule with the concomitant evolution of carbon dioxide. 
This reaction is already known as a stage of fatty acid 
biosynthesis and at first would appear to be the most 
likely pathway for the biosynthesis of acetoacetate. 
However, it has been shown 36 that incorporation of 
acetyl-00A (13) into isoprenoids in cell free preparations 
14 
of rat liver was not inhibited by avidin and was not 
stimulated by bicarbonate. 	Avidin is a protein which 
binds very strongly to biotin (the prosthetic group of 
acetyl-00A carboxylase) (step 1, Scheme 3). Thus lack of 
inhibition of isoprenoid biosynthesis by its presence 
suggests that carboxylation of acetyl-00A and the inalonate 
pathway are not involved in the synthesis of isoprenoids. 
Moreover, the labelling patterns of HMG-00A (15) formed 
from [2_14C ]  and (1,3-14C2] malonyF-CoA (33) in rat and 
pigeon liver preparations were those that would be 
expected if malonyl-CoA underwent decarboxylation to 
acetyl-CoA (13) before incorporation 36 . 
The incorporation of 13C labelled acetates into the 
monoterpenoid derived C10 unit of indole alkaloids such as 
ajmalicine (37) from tissue cultures of the plant 
Cat*anthus roseus have also been found to be at variance 
with the pattern predicted by the acetoacetate pathway37 . 




predicted (1,2 3C,) acetate inc. 
pattern via acetoacetate pathway 
15 
The 13C NMR spectrum of ajmalicine (37) derived from 
[2-13C] acetate showed enrichment at C-16, 17, 18, 19 and 
20 positions, [1-13C] acetate derived ajmalicine (37) 
showed no enhancement of signal intensities over natural 
abundance and [1,2_13C2]  acetate derived ajmalicine (37) 
showed the same pattern as (2-13C] acetate but no 
multiplet signals corresponding to the incorporation of 
intact acetate units. The loss of acetate 13C carboxy 
enrichment and the redistribution of 13C labelling from 
the methyl group into two adjacent positions (which are 
formally derived from the same acetate molecule) indicates 
that extensive randomisation of acetate 1 3C methyl 
enrichment via the Krebs cycle (see Appendix) occurs to 
afford a mixture of [2_13C]  and [1-13C] acetate before 
incorporation to mevalonic acid (16). 	The 
regiospecificity of incorporation at the carbon atoms 
derived from the methyl and quaternary carbons suggests 
that HMGC0A (15) may be undergoing metabolic cycling 
(Scheme 4). The existence of such a futile cycle in the 
acetoacetate mevaloriate pathway permits rationalisation of 
the variable enrichments obtained in earlier studies of 
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4. PROKARYOTIC ISOPRENOID BIOSYNTHESIS 
The acetoacetate pathway (Scheme 1), considered to be 
proven for eukaryotes, has been generally assumed to be 
the route utilised by prokaryotes. There is indeed some 
evidence to support this view 3  
A few of the acetoacetate pathway enzymes have been 
separated from bacteria and their properties investigated. 
HMGCoA reductase has been purified from Pseudomonas 39 to 
over 95% homogeneity and 38.9 mol/mg min-' specific 
activity by gel electrophoresis. It is unusual in that it 
appears to be a multifunctional enzyme which catalyses all 
of the reactions in Scheme 5. Mammalian liver and yeast 
2H+2NADH 2NAd+CoASH 	 0 	OH 









HHGC0A reductases are reported only to catalyse reductive 
deacylation of HMGC0A (15) to mevalonate (16) essentially 
irreversibly39. 	Mevalonate kinase has been found in a 
cell free extract from a phytoene (39) accumulating 
Staphylococcus 40 ' 41 mutant and shown to convert mevalonic 
acid (16) into mevalonate- 5-phosphate (17). 	Isopentenyl 
pyrophosphate isomerase has only recently been separated 
chromatographically from an extract of Escherichia coli 42  
and assayed in a cell free extract of Streptomyces 
arenae 43. 	In contrast to yeast and mammalian systems 
there is little information available on the enzymes of 
the acetoacetate pathway in bacteria. To date there have 
been no reports of bacterial HMGC0A synthase, 
mevaionate5-phosphate kinase or mevalonate pyrophosphate 
decarboxylase. 
(39) 
Some isotopic tracers have been incorporated into 
bacterial isoprenoids in a way consistent with the 
isoprenoid pathway. In studies on the mechanism Of 3-ring 
cyclisation in carotenoids, [2-13C] mevalonate was 
incorporated into zeaxanthin (40) and its acyclic 
19 
precursor lycopene (41) in Flavobacteriun'x44 . 	' C NNR 
analysis showed 'C enrichment in both compounds at C-4, 
8, 12, 16, 41, 81, 12' and 16' as would be expected via 
the acetoacetate pathway. 	Cell free systems from 
Corynebacterium poinsettiae and Micrococcus luteus 45  
incorporated various 14C and 3H labelled mevalonic acids 
into acyclic C40 and cyclic C 0 carotenoids, e.g. 
sarcinaxanthin (42). The 14C/3H ratios obtained were used 






During whole cell studies on the elucidation of the 
chemical structure of unsaponifiable lipids, [2-"4C] 
mevalonic acid was incorporated into undecaprenol (C 55 ) in 
Lactobacillus caesi46. 	The conversion of [2 14C] 
mevalonic acid into unsaponifiable lipids has also been 
demonstrated with lysates of Lactobacillus plantarurn47. 
The total lipids of the archaebacterium 
Methanaospiriliuni hungates48 were analysed by 'C NNR 
after growth on 13C labelled acetates and 13C labelled 
carbon dioxide. In common with other.archáebacteria 94% 
of the lipids were derivatives of diphantanyl glycerol 
(43) and bidiphantanyl glycerol (44). 	The labelling 
pattern, with each phytanyl C. chain fragment originating 
from one molecule of mevalonate, was consistent with the 
typical condensation of three acetate units to form one 
mevalonate (16) molecule. 
0  
(43) 
EH 	 J2 (44) 
2]. 
The same 13C acetate labelling patterns were observed 
in the lipids of the extreme thermophilic archaebacterium 
Caldariella acidophila49. Structure (45) shows the mixed 
biogenesis metabolite caldariellaquinone49 after [1 13C) 
and [2 13C] acetate incorporations. Moreover, the 13C NMR 
spectra of its hydrocarbons5° (46)-(49) after 
incorporation of [1,2-13C 2] acetate showed C-4, 41, 8, 8;, 
12, 12', 16 and 16' as singlets of enhanced intensity and 
the rest as multiplets with satellite pairs due to 'C-'C 
coupling ('cc35  Hz). 	This indicated incorporation of 
two intact acetate residues per C. unit as would be 
expected via the acetoacetate pathway. 
(45) 
0 	from (1- 3C) acetate 	S 	from (2-13C) acetate 
1' 
22 
17 	 18 
19 	





5. ALTERNATIVE PROKARYOTIC PATHWAYS 
As with eukaryotes, a number of analogous 
incorporations of isotopically enriched precursors have 
been described and alternative pathways proposed5 1 , 5 2 
It has been reported recently that inevalonic acid is 
not synthesised from three acetyl-00A units in the aerobic 
archaebacteria Hal oba Ct en urn curtirubrum and Halobacterium 
halobiurn51 . 	13C Labelling studies have confirmed the 
incorporation of acetate into phytanyl chains (43) and 
(44), presumably via acetyl-CoA, but revealed an 
unexpected lack of label transfer from acetate, glycerol 
or alanine to the branch methyl and methine carbon atoms. 
Thus, it appears that of the three two carbon units 
normally used as precursors of mevalonate (16) only two 
originate from acetate. 	'C Labelled amino acids, 
especially leucine, were found to label the lipids but the 




This is quite surprising as there is no knowledge of 
any metabolic route for converting lysine to the phytanyl 
chains of lipids. A general scheme for the utilisation of 

















It is possible that the general scheme of the biosynthesis 
is the same as in higher organisms proceeding via 
acetyl-00A and the basic difference lies in the enzymes 
used by halobacteria. 	Operation of a mixed thiolase, 
which could use acetyl-00A derived from acetate and 
acetyl-X derived from degraded amino acids, would explain 
the labelling pattern of the phytanyl chains observed in 
halobacteria. The malonate pathway (Scheme 3) has also 
been invoked as a possible explanation for these anomalous 
results5 1 
The pattern of incorporation of radioactivity from 
[1 14C] acetate and [2-'4C] acetate into the polyprenyl 
side chain of ubiquinone-10 (51) in Rhodopseudomonus 
capsulata52 has also been studied. Labels from both 14C 
labelled acetates were found to be incorporated 
exclusively into the C-2 position of laevulinic acid (52) 
(a degradation product of the polyprenyl side chain) 
suggesting that the acetoacetate pathway was not operative 
in this bacterium. 
.0 
CH 30 
CH 30 o  40 
i4 [0] 
(51) 	 5 
SCHEME 6 
Furthermore, the patterns of incorporation of 
radioactivity from [U-14C] valine (53),(U-14C] alanine 
(54) and ['4C] sodium bicarbonate into the side chain of 
ubiquinone-10 (51) in Rh. capsulata were used as evidence 
of an alternative route to mevalonic acid (16) via the 
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(20) 	 (23) 
SCHEME 7  
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(57) 0 H 	
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CO2H 
OH yo f 5r, 90), 
The sequence begins with the condensation of pyruvate (55) 
(a degradation product of alanine (54)) and acetaldehyde 
(56) to give acetolactate (57) which rearranges to give 
2-oxoisovalerate (58) (a degradation product of valine 
(53)). A 1,2 shift of the tertiary alcohol (59) followed 
by oxidation gives 2-oxo-4-methylpentanoate (23) which is 
then said to elaborate isoprenoids via leucine catabolism 
27 
(see Scheme 2). Radioactivity from [U-14C] alanine and 
[U-14C] valine was distributed evenly among the Cl, 3, 4 
and 5 carbons of laevulinic acid (52) with negligible 
radioactivity in C-2. 	Radioactivity from ['C] sodium 
bicarbonate was incorporated exclusively into the C-2 
carbon of laevulinic acid (52). 	It was proposed that 
incorporation of the labelled C-2 carbon of acetate was, 
also via carbon dioxide. 	A mechanism for the 
incorporation of carbon dioxide is shown in Scheme 8. All 
of these results are fully in accordance with biosynthesis 
via. the acetolactate pathway and although it cannot be 
argued that all bacteria synthesise isoprenoids through 
the acetolactate pathway preliminary evidence has also 
been claimed for its existence in Lactobacillus caesi 52 . 
S 
.•"iLSCoA 	HO ' "SCoA 	HO' " SCoA 




HO SCoA -a-- 	 'SCoA 	 H 14 	
(27) 
OPP 	 SCHEME 8 
(20) 
28 
6. PRELIMINARY FEEDING STUDIES 
In an earlier study in this laboratory53 a series of 
stable isotope precursor feeding experiments were carried 
out in Rh. capsulata to elucidate whether the acetolactate 
pathway was indeed involved in the generation of the 
isoprenoid side chain of ubiquinone-10 (51). The results 
of these earlier studies are shown in Table 1 together 
with: the anticipated labelling patterns which would 
arise from the acetolactate and acetoacetate routes, the 
observed incorporations of radioactive precursors leading 
to the proposed acetolactate pathway and the stable 
isotope incorporation patterns in the polyprenyl side 
chain of caldariellaquinone (45) from Caldariella 
acidophila 49 . 
In general terms the stable isotope studies in Rh. 
capsulata53 and Cald. acidophila 49 are at variance with 
the 	radioisotope study in Rh. capsulata5 2 although 
relatively consistent with each other. In particular, the 
stable isotope studies show much less specific 
incorporation of 13C labelled acetates into the isoprene 
C'4 carbon (laevulinic C2) and there was no incorporation 
of [3'3C] LD-valine into ubiquinone-10 (51) in Rh. 
capsulatä as would be predicted by the acetolactate 
pathway. 
PREDICTED INCORPORATIONS 	 OBSERVED INCORPORATIONS 
CALD. ACIDOPHILA 	* RHCAPSULATA 	RH. CAPSULATA 
PRECURSOR 	ACETOACETATE 	ACETOLACTATE  
	
CALDARIELLAQUINONE UBIQUINONE 10 UBIQUINONE 10 
(U-13C6) glucose 
41 	2 
(1.2-13C2) acetate 	 1J....._ 	 _.•..,..,.l......___#_ 




 F2 	 1•1 	 072 
3-3 	 93-67 (I-'3C) acetate 	 . 	 •._-_::J._. 
FO 	.5 	 1.44 	1*44 
1.1 	 1.18 
NaH13CO3 	 none 	 18 	1.0 	 9 h7 18, 
1-5 
(3,4-13 	 1.0 C) glucose 
4-2 
2373 
(3-13C) DL-ak&,ine 	 4•.•.1I.I•.••.. 
24-55 
(3-13C) DL-valine 	 none 	 none 	 1-10 	24-24 
2543 	2468 
* Obtained from preliminary feeding studies done in this laboratory, expressed as a multiple of 13C NMR natural abundance intensities. 
** Expressed as a % of total incorporation 
'TABLE I 
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Stable isotope [ 13c 6 ] glucose and [' 3C 2] acetate 
studies in Rh. capsulata showed the expected acetoäcetate 
pathway incorporation patterns, with 13C-13C couplings 
indicating incorporation of two intact acetate molecules 
per isoprene unit as observed with the hydrocarbons 
(46)(49) of Cald, acidophila 50. Singly labelled stable 
isotope [ 13C] acetates however, did not show the expected 
acetoacetate or acetolactate incorporation patterns, both 
[1 13CJ acetate and [2-13C] acetate studies show 
scrambling 	but 	more 	conspicuously, 	anomalous 
incorporations in the isoprene C-5 carbon. 
No comparison with the 13C incorporation patterns of 
the unsaponifiable lipids of Cald. acidophila could be 
made at this point. 	In the 13C NMR spectrum of 
caldariellaquinone49 (45) no distinction could be made 
between the isoprene C-5 and C-3 carbons and no 
information on the intensities of incorporations. of 1 
labelled acetates into the hydrocarbons (46)-(49) has been 
reported. 
In Rh. capsulata [1_13C] acetate gave significantly 
higher incorporation into the isoprene C-5 carbon than 
predicted by either the acetoacetate or acetolactate 
pathways. 	It is conjectured that [1-13C] acetate is 
losing its 13C enrichment in the form of carbon dioxide 
while being metabolised in the Kreb's cycle (see 
Appendix). This carbon dioxide is then reincorporated via 
the Calvin cycle (see Appendix) into glucose-6-phosphate 
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and ultimately ubiquinone-10 (51). 	In support of this 
view [ 13C] sodium bicarbonate was incorporated 
specifically at the isoprene C-5 position. 
Absence of 13C enrichment at the C5 isoprene carbon 
after [2 1 C] acetate incorporation in Rh. capsulata 
together with the [1-1 C] acetate incorporation pattern 
suggested that a molecular species other than a third 
acetate may be. condensing with acetoacetyl-CoA (14) in the 
biosynthesis of isoprenoids. It was subsequently proposed 
that either pyruvate (55) or its biological equivalent 
acetaldehyde (56) might be involved. 	This view was 
supported by the incorporation of [3,4_ 13C 2 ] glucose 
specifically into the isoprene C-5 carbon. 	[3,4_ 1 3C 2 ] 
Glucose is metabolised via the Entner-Doudoroff pathway 
(see.. Appendix) to (3 1 C] pyruvate and [1-13C] 
g1yceraldehyde-3-phosphate. In the event of an analogous 
pyruvate-acetoacety1-CoA condensation to that of 
acety1CoA (1.3) and acetoacety1-CoA (14), [3-13C] pyruvate 
would enrich the isoprene C-5 carbon as was observed. 
The condensation of pyruvate (55) and acetoacety1-CoA 
(14) would also explain the [ 13C] bicarbonate and [1-1 C] 
acetate results. [ 13C] Carbon dioxide would give [3-13C] 
glucose-6-phosphate after incorporation via the Calvin 
cycle, subsequent metabolism via the Entner-Doudoroff 
cycle would give (3 13C) pyruvate and condensation with 
acetoacetyl-00A would enrich the isoprene C-5 carbon as 
was observed. 
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The result, of pyruvate (55) and acetaldehyde (56) 
condensations with acetoacetyl-00A are shown in Scheme 9. 
Reduction of the HMGCoA analogues (62) and (64) in an 
analogous way to that of HNGC0A (15) would give the 
mevalonic acid analogues (38) and (65). 	Subsequent 
cyclisation would give 2,4-dihydroxy-4-methyltetra-
hydropyran (63) and 2-carboxy-2, 4-dihydroxy-4-methyl 
tetrahydropyran (66). Isopentenyl pyrophosphate formation 
from these tetrahydropyrans could be envisaged via the 
mechanisms shown (Scheme 10). 
In order to test these possibilities it was necessary 
to synthesise. the tetrahydropyrans (63) and (66) in a 
labelled form. Specific incorporation of these advanced 
precursors would then definitively prove the existence of 
this alternative pathway to isoprenoids in Rh. capsulata. 
The remainder of this thesis describes synthetic 
approaches towards these tetrahydropyrans, the results of 
advanced precursor feeding studies and the assay of HMGC0A 
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CHAPTER 1: 	SYNTHESIS OF 2.4-DIHYDROXY-4-METHYL- 
TETRAHYDROPYRAN (63) 
1.1 	RETROSYNTHETIC ANALYSIS 
Retrosynthetic analysis' 5'56 of the structure (63) 
was carried out and revealed many plausible routes. 
























C 	 - 
SCHEME 11 
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Cleavage of the heiniacetal (63) endo CO bond results 
in aldehyde and alcohol functionalities (38) which would 
be expected to spontaneously cyclise. 	The immediate 
synthetic precursor of (38) would therefore logically have 
to contain a protected aldehyde moiety. 	Two possible 
protection strategies involve either generation of the 
aldehyde from ozonolysis of the alkene (71) (Strategy 1) 
or protection of the aldehyde as an acetal (75) and 
subsequent deprotection by mild acid hydrolysis (Strategy 
2). 
In Strategy 1, synthesis of the alkene •(71) could be 
effected by Grignard Reaction of allyl bromide (73) with 
3-oxobutan-1-o1 (72) although it would be more economic to 
protect the alcohol and use only one equivalent of 
Grignard reagent. Tetrahydropyranyl protection appeared 
to be a good choice in this case as the group is stable to 
Grignard conditions and easily removed by mild acid 
catalysis. 
In Strategy 2, cleavage of the acetal (75) as shown 
reveals the ketoacetal (77) and a two carbon anion synthon 
(76), the synthetic equivalent of which is ethyl acetate 
(78). The C-C bond could thus be created by reaction of 
the lithium enolate of ethyl acetate (78) with the ketone 
of the ketoacetal (77). 	Subsequent lithium aluminium 
hydride reduction of the ester would give the primay 
alcohol moiety. 
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1.2 	STRATEGY 1 
1.2.1 	Establishinc a Route 
Initial attempts at synthesis of 3-oxobutan-1-ol (72) 
from acetone (79) and paraformaldehyde (80) using one 
equivalent of 3N methanolic potassium hydroxide as base 
gave low yields (reported as 27%) 57 of impure product. 
Attempts to purify the product by fractional distillation 
and chromatography were unsuccessful and further synthesis 
using the compound at, the achievable level of purity led 
to intractable mixtures. 
A more successful route invoked a Michael reaction. 
Hydration of dihydropyrari58 (81). using hydrochloric acid. 
gave 2hydroxytetrahydropyran (67%) (82) which, when 
reacted with methyl vinyl ketone (83) in the presence of a 
catalytic amount of 3N methanolic potassium hydroxide59 , 
gave a 67% yield of 1-(tetrahydropyranyl-2-oxy)-
butan3one (74). 








0- 	0 O 
(81) 	 (82) 
SCHEME 12 
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Grignard reaction of allyl bromide (73) with the 
ketone (74) gave a mixture of the monoprotected diol (50%) 
(84) and the unprotected diol (22%) (71). Acid catalysed 
hydrolysis of the tetrahydropyranyl protections 0  from (84) 
gave the diol (71) which was subjected to ozonolysis 6 l at 
-78°C to give a high yield (90%) of the 
dihydroxytetrahydropyran (63) on reductive work up with 
triphenyiphosphine. The structure of the tetrahydropyran 
(63) is discussed in Part 1.5. 
6  OT H P 	
0TH P 	'0000 	OH OH 
(74) 	
(84) 	 (71) 	 (63) 
SCHEME 13 
1.2.2 	Labelled Synthesis of (63) 
Analysis of Strategy 1 reveals 1-(tetrahydropyranyl-2-
oxy)-butan-3-one (74) to be the most feasible target for 
inserting a stable carbon isotope as labelled allyl 
bromide (73) cannot be made cheaply. Labelling the methyl 
group of the ketone (74) (which becomes the 4-methyl in 
the dihydroxytetrahydropyran (63)) requires a synthesis of 
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the ketone (74) in which introduction of this carbon could 
be made at a late stage. 	The standard routes for 
introduction of a methyl group include use of 
organocadmium reagents62, Grignard reaction on nitriles63 , 
alkyl lithium reagents with lithium salts of carboxylic 
acids 64 and reaction of a methyl Gricnard reagent with an 
aldehyde followed by oxidation of the secondary alcohol. 
Of these options the latter two were tried. 
2Hydroxytetrahydropyran 	(82) 	formed 	a 
tetrahydropyranyl protected 3-hydroxyester (86) on 
reaction with methyl acrylate (85)59 and methanolic 
potassium hydroxide in a Michael reaction analogous to 
that used in Scheme 12. Saponification of the ester (86) 
with 10% sodium hydroxide gave the free acid (87). 
Attempts to form the ketone (74) on reaction of the 
corresponding lithium salt of (87) with methyl lithium 65  
were unsuccessful. 	While it is not certain why this 
reaction failed, the isolation of 2-hydroxytetrahydropyran 
(82) as a principal product suggested that degradation of 
the acid (87) possibly via a retro-Michael reaction 
(Scheme 14) had occurred. 
aOO H 0 	 0 0 
MeO'' 
-(82) 	
MeO '0THP H0""0THP 
(85) 	 (86) 	 (87) 
SCHEME 14 
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The second strategy outlined in Scheme 15 proved more 
useful. 	The monoprotected diol (89) was prepared for 
initial experiments from the -hydroxyester (86) by 
reduction with lithium aluminium hydride 66 . Subsequently, 
it was found more convenient to prepare this compound (89) 
by reaction of propane-1,3-'diol (88) with one equivalent 
of dihydropyran (81)58 albeit in only 37% yield. 	This 
latter route was justified by the economy and ease of 
reaction. Oxidation of the alcohol (89) with pyridiniuin 
chlorochromateG? to the aldehyde (90), followed by 
Grignard reaction6 l with methyl magnesium iodide and 
oxidation of the resulting secondary alcohol (91) with 
pyridiniuni chlorochromate, gave the target ketone (74) in 
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Since the stable carbon isotope was to be introduced 
in the form of iodomethane, the overall yield of label 
incorporated into the hydroxytetrahydropyran (63) would be 
9%, the worst step in the route being the Grignard 
reaction of methyl magnesium iodide with aldehyde (90) 
yield (33%). (This could possibly have been increased by 
using excess Grignard reagent although this would be 
impractical in terms of a labelled synthesis). 	It was 
hoped that changing the order of the Grignard reactions 
(Scheme 16), i.e. reacting allyl magnesium bromide with 
the aldehyde (90) and methyl magnesium iodide with the 
ketone (93), would permit introduction of the label at a 
later stage in the synthesis and lead to an improved 
yield. Reaction of the aldehyde (90) and allyl magnesium 
bromide however did not give the alcohol (92) possibly due 
to an ene reaction. Attempts to synthesise the ketone via 
deprotection of the dithiane68 1 69 1 20 (94) and reaction of 
allyl magnesium bromide with the nitrile (95)71  were also 
unsuccessful. 
OO-- I P 	 -"OTH P 	 HP 
(so) 	 (92) 	 (93) 
VOH 
' OTHp 	 _1 




1.3 	STRATEGY 2 
1.3.1 	Establishing a Route 
The second strategy72 turned out to be the most 
efficient in terms of label incorporation into the final 
product (63) (Scheme 17). Aldol reaction of acetone (97) 
and methyl formate (96) gave a 14% yield of the ketone 
(77). Reaction of the lithium enolate73 of ethyl acetate 
with ketone (77) and lithium aluminium hydride reduction 
of the ester (98) gave the diol (75) which cyclised on 
stirring with acidic ion exchange resin in methanol to 
give a mixture of diastereomeric acetals (99). 	The 
structures of the acetals are discussed in Part 1.5. 
Hydrolysis of the acetal mixture (99) was effected using 
acidic ion exchange resin giving a mixture of heiniacetals 
(63) in an overall yield of 41% from ethyl acetate and the 
ketone (77). 
0.Ik 
	 0 	 OH 
HOMe ____________ 	- 	 0 E 
(96)MeO2 'OMe 	MeO"OMe 
(77) 	 98) 
OH 	 H 	 OH 
110  (n (n 	 0 	 AOMe  0 OH 
	
We 	MeO OH 
(63) () (75) 
SCHEME 17 
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1.3.2 	Labelled Synthesis of (63) 
This strategy was then used in the labelled synthesis 
of the dihydroxytetrahydropyran (63) with some 
modifications to accommodate the use of sodium acetate 
(100) as a labelled starting material (Scheme 18). 
On 	ref lux with tri-n-butylphosphate, sodium acetate 
(100) was esterified to its n-butyl ester (101) (which is 
less volatile than ethyl acetate and therefore more easily 
handled). 	The lithium enolate of the ester (101) was 
reacted with the ketone (77) in an analogous manner to 
that carried out with the lithium enolate of ethyl acetate 
in Scheme 17. Lithium aluminium hydride reduction of the 
ester (102) gave the diol (75). The rest of the synthesis 
was carried out as described previously. The route was 
used to synthesise both [5-1 C] and [5,6-'3C 2 ] 
dihydroxytetrahydropyrans (63) from [2-13C] sodium acetate 
and [l,2-13C 2] sodium acetate respectively. The overall 
yield for the five steps was 33%. 
OH 	 OH 
0 	 0 
"ONa 	 OBUu1MeO'OMe 	 Me0LOpOH 




1.4 	STRATEGY 3 
It was later found that the acetal (63) could be 
synthesised by the diisobutylaluminiuin hydride reduction 
of mevalonic lactone (61) followed by an acidic methanol 
work up. The unoptilnised overall yield of 50% makes this 
a viable two step route to the target 
dihydroxytetrahydropyran (63) as there are many 
established routes to labelled mevalonic lactone 
(61)72,70,61 (Scheme 19). 
OH 	 OH 





1.5 	STRUCTURES OF THE TETRAHYDROPYRANS (63) AND (99) 
1.5.1 	4Hvdroxv4-methyl-2-inethoxvtetrahydropvran (99) 
The title compound can be prepared either by acidic 
cyclisation of the acetal (75) or by reduction of 
mevalonic lactone (61). 	Both of these methods give a 
mixture of two diastereomeric pairs of enantiomers (Figure 
5) which can be separated by flash column chromatography 
on silica. 	The diastereomers (99a) and (99b) were 
isolated in ratios of approximately 1:3. 	The major 
diastereoiner (99b) was found to be the more polar with a 
boiling point of 46°C at 0.75 mm Hg as opposed to 60°C at 
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8 mm Hg for (99a). 
Assignment of the relative configurations of the two 
diastereomeric acetals was based on 'H NNR data. 
Accompanying the structures (99a) and (99b) in Figure 5 
are the 'H NNR. spectra of their respective C-i hydrogens. 
The large coupling 7,8 Hz in Figure 5 enables assignment 
of the C-i proton of (99b) as axial. The absence of such 
a large coupling in the spectrum of (99a) suggests that 
its C-1 proton is equtorial. Complete assignment of the 
'H-'H coupling constants obtained for both diastereomers 
from 360 MHz 'H NMR spectra are shown in Figure 5. 
NOE difference spectroscopy (see Table 2 for NOE data) 
confirmed the assignment of the confcyration of the C-3 
position. 	Irradiation of the methyl group in each 
diastereomer did not increase the intensity of the C-i or 
C-5 axial proton signals, thus the methyl group has to be 
equatorial in both cases. 	This was confirmed by the 
irradiation of the C-5 axial protons which showed no 
increase in the intensity of the methyl signal of either 
diastereomer. Irradiation of the C-5 axial protons also 
showed a 4% increase in the intensity of the C-i proton 
signal of (99b) and no increase in the C-i proton signal 
of (99a). 	This confirmed the assignment of the C-i 
protons of (99a) and (99b) as equAtorial and axial 
respectively. 
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99b irr < 	i% 
irr 	 6% 
3% 	1% 	2% 
	
irr 
2% 	 irr 5% 4% 




1% 1% irr 
irr 14% 
1% 	 13% irr 
(irr = proton irradiated) 
(% 	= increase in neighbouring protons signal) 
Table 2 
3 11 eq2ax  =3.6 
Ieq2eq - 1.6 - 
'Ieq4eq - 0.8 
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The more polar nature of (99b) exhibited in its t.l.c. 
and b.p. characteristics can be explained from these 
structural assignments. Intramolecular hydrogen bonding 
present only in (99a) makes it less capable of 
intermolecular hydrogen bonding and thus more volatile. 
The other diastereomer (99b) is incapable of 
intramolecular hydrogen bonding because of the distance 
between the hydroxy and methoxy groups. 
1.5.2 	2 4-Dihydroxv-4-methvltetrahvdropyan (63) 
The title compound can be prepared either by 
ozonolysis of the alkene (71). or by hydrolysis of the 
acetal (99). Both methods gave a mixture of diastereomers 
which could only be separated with difficulty by flash 
column chromatography on silica. Although the ratio of 
the two diastereomeric pairs of enantiomers varied with 
the method of preparation, 'C NNR spectra of the mixture 
typically showed an intensity ratio of around 3:10 for the 
methyl signals at o 30.2 and 30.9 ppm. 
The structure of the predominant diastereomer (63a) 
(Figure 6) was deduced by comparison of its 13C NNR and 'H 
NMR spectra with those of the acetals (99a) and (99b). 
The minor diastereomer (63b) was however never obtained in 
a pure enough form for rigorous NNR characterisation. 
It can be seen from the 'H NNR spectra of the H5eq, 
H5ax, H4ax and H2ax proton signals in Figures 6 and 7 that 
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(63a) correlates very closely in both chemical shift and 
arrangement of couplings with (99a) (Figure 5). The H5eq 
proton for example (Figure 6) resonates at 5 3.6 ppm in 
both cases and has four couplings of 11.8, 5.3, 1.7 and 
0.6 Hz in the acetal case (99a) as compared with 11.9, 
5,3, 2.0 and 0.4 Hz for (63a). This contrasts with the 
H5eq proton of (99b) which resonates at 6 3.8 ppm and has 
five couplings of 11.7, 4.9, 4.0, 0.4 and 0.3 Hz (Figure 
6). The observed couplings for (63a) are also shown in 
figure 6. 
The 13C NMR data supports the IH NMR structural 
assignment (Table 3). Four out of six of the 13C n.m.r. 
resonances of (63a) are closer to those of (99a) than 
(99b) with four of them being within 0.7 ppm. The other 
diastereomer (63b) shows analogy with the acetal (99b) 
with four out of six 13C NMR resonances closer to it than 
(99a), and three within 0.7 ppm. 
C]. 	C2 	C3 	C4 	C5 	Me 
63a 92.1 41.0 68.0 37.9 55..6 30.2 
63b 93.0 45.2 69.2 37.8 61.2 30.9 
99a 98.8 40.9 66.5 37.9 54.9 29.8 
99b 99.8 43.8 69.0 38.4 55.9 30.6 
Table 3 
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The preferred conformation of a 2-hydroxy 
tetrahydropyran is to have an axial hydroxy group, the 
anomeric effect stabilises this isomer by ,r_a* back 
bonding74. 	In accordance with this the major 
dihydroxytetrahydropyran (63a) has an axial 2-hydroxy 
substituent, the major acetal (99b) (56%) however is found 
to have an equatorial 2-methoxy. 	In the latter case the 
increased 1,3 diaxial interactions of the methoxy group 
are of sufficient destabilising nature to make it take up 
the equatorial conformation.. 
It is notable that some long range couplings are 
observed in these ring systems' 52eq5ax = 0.6 Hz in both 
(63,a) and (99a), 52eq5eq = 0.3 Hz in (99b),, 5 ieq4eq = 
0.7 Hz in (63a), and 5ieq4eq = 0.8 Hz in (99a). Large W 
couplings are also observed, 42eq4eq = 2.5 Hz in (99a) 
and 4J2eq4eq = 2.6 Hz in (63a) and a four bond diaxial 
coupling 42ax4ax = 0.8 Hz in (99b). The observation of 
the long range coupling is a consequence of the rigidity 
of the ring systems. 	 . 
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CHAPTER 2: 	TOWARDS THE SYNTHESIS OF 2-CARBOXY-2.4- 
DIHYDROXY-4 -METHYLTETRAHYDROPYRAN (66) 
2.1 STRATEGY 1 
Before any chemical reactions were attempted the 
target molecule (103) Scheme (20) was retrosynthetically 
analysed54i 55'56. 	Cleavage of the endo hemiketal bond 
reveals an a-ketoester (104), this functionality has few 
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RBr(106) 
Using a similar strategy to that described in Scheme 
17, the lithium enolate of 	ethyl pyruvate (105) or the 
Reformatsky reagent of bromoethylpyruvate (106) could be 
surmised to react with the ketone (74) (the synthesis of 
which was described in Chapter 1) and form the desired, 
protected a-ketoester (104). 	Removal of the THP 
protection and cyclisation would result in formation of 
the target molecule (103). However, both of the attempted 
carbon-carbon bond forming reactions gave complex mixtures 
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from which the only characterisable product was the 
starting material ketone (74). Attempts at reacting the 
lithium enolate of ethylpyruvate (105) with the more 
reactive carbonyl of benzaldehyde also failed possibly 
because the enolate reacts with itself. 
22 STRATEGY 2 
It is well known that ruthenium tetroxide oxidises 
alkynes to c-diketones75 and it has been shown more 
recently that osmium tetroxide oxidises l-trimethyl 
silylalkynes to crketoesters. Bromo alkynes have also 
been shown to be oxidised to a-ketoacids by ozonolysis??. 
It was therefore proposed that oxidation of the 
trimethylsilyl alkyne (109) (Scheme 21) would provide a 
route to the a-ketoester (108) and subsequent cyclisation 













Synthesis of the trimethylsilylalkyne (109) was 
relatively straightforward although low yielding (11% for 
the four steps) (Scheme 22). 	Reaction of propargyl 
alcohol (110) with triinethylsilylchloride, after 
activation with ethylmagnesiumbroiuide, gave the 
trimethylsilylalcohol (111)78. 	Reaction of the alcohol 
(111) with triphenylphosphine and bromine78 gave the 
bromoalkyne (112) which formed the protected diol (113) on 
reaction of its Reformatsky reagent79 with the ketone 
(74). Aqueous acid hydrolysis removed the THP protection 
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Attempted oxidation of the alkyne (109) using both 
catalytic and quantitative amounts of osmium tetroxide 78  
resulted in formation of complex mixtures of products. 
The consumption of the starting material suggests that the 
reaction conditions were too harsh for the successful 
preparation of the target tetrahydropyran (107). 
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Ozonolysis of the alkyne (109) gave a more polar 
product which showed some of the expected target molecule 
characteristics. Although the FAB mass spectrum showed no 
molecular ion, two significant fragments at m/z 173 and 
m/z 155 were observed. 	These fragments suggest the 
presence of the ester (107) as they correspond to loss of 
a hydroxyl group and subsequent loss of a water molecule 
from a molecular ion of m/z 190. The 13C NNR spectrum was 
also consistent with the proposed structure showing an 
anomeric carbon resonance at a 95 ppm and seven other 
major carbon resonances.. These resonances, in particular 
the anomeric carbon, suggested the presence of a 
tetrahydropyran ring. , The jnfra red spectrum showed 
carbonyl adsorptions at 1700-1770 cm-1 and hydroxyl 
adsorptions at 3500 citrl consistent with the proposed 
structure and the 1H NNR spectrum, although complex showed 
resonances in the predicted regions. It is to be noted 
that on standing at room temperature over a few weeks the 
sample became contaminated with mevalonic lactone '(61). 
Although the evidence strongly suggests the successful 
synthesis of the target molecule (107) the route is not 
viable as a labelled synthesis 'because of the low yield of 
label incorporation into the target molecule, 
approximately 4% from [ 13C] methyliodide via the ketone 
(74) (Scheme 15). 
23 STRATEGY 3 
The third strategy to the tetrahydropyran (114) is 
based on the a-keto acid protecting "ylidene dioxolanone" 
methodology used recently in the synthesis of the 
1 ipopolysaccharide sugar 3 -deoxy-D-mannooctu1osonic acid 
(KDO)8 ° (119). Analysing the strategy retrosynthetically 
(Scheme 23), tautomerism of the a-rketone in the a-keto 
acid (115) gives the 1,2 diol (116) 	This diol (116) 
could then be derived from the 5ylidene1,3dioxo1an-4-
















The 1,3-dioxolan-4-one (118) is stable to acid and can be 
cleaved under mild base hydrolysis conditions to give the 
a-keto acid (119) as its barium salt (Scheme 24)80. 
HO OH 





Thus hydrolysis of the 1,3-dioxolan-4-one (117) should 
give the barium salt of the a-keto acid (115) which should 
spontaneously cyclise to give (114). 
The desired 1,3-dioxolan-4-one derivative (117) could 
be conjectured to be formed from the Wittig reaction of 
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However the aldehyde (120) cannot be used in this case as 
it would be expected to spontaneously cyclise to a 
tetrahydrofuran0 THP protection of the primary alcohol 
would stop this cyclisation. 
Attempted synthesis of the aldehyde (126) (Scheme 26) 
used the ketone (74) as a starting material. 	Reaction 
with the Wittig reagent methyltriphenyiphosphonium 
iodide8 ' gave the protected isopentenyl alcohol (123) 
which was also made by THP protection of the alcohol 
(122). 	Reaction of the alkene (123), with 
metachloroperbenzoic acid82 gave the epoxide (124) which 
formed the diol (125) when refluxed overnight with 5N 
sodium hydroxide. Attempted oxidation of the diol (125) 
with pyridinium chlorochromate 6 resulted in a 
reaction giving the original ketone (74) (77% yield) 
instead of the desired aldehyde (126). 
R" 	 R OEt 	R & OH 	O <O  
(127) 	 (128 	 (129) 	R>L" 
	
R'= —CH20THP (a) 	(i) R2= R3 = Me 	 (130) 
—CH20CH2Ph (b) 	(ii) R2 Me, R3=H 
—CHS(CH2)(c) 	
RkR3 
0 0 UJ 	 I 
0 
- —CHCH2 	(e) 
H 
—CHCMe2 	(f) 	 (131) 
SCHEME 27 
While it may have proven possible to generate the 
desired aldehyde (12 6) by other procedures - for example 
by ozonolysis of the alkene (.129e) after THP protection of 
the primary alcohol (Scheme 27), an alternative strategy 
involving the construction of the diprotected synthon 
(131) (Scheme 27) was more attractive. Synthesis of the 
target skeleton (131) was attempted via an ethyl acetate 
lithium enolate strategy (cf Scheme 17) as 13C label could 
easily be incorporated from 13C labelled sodium acetate. 
A range of aldehyde (a-f) and diol ((i), (ii)) protection 
strategies were evaluated and are summarised in Scheme 27. 
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The principal problem encountered was the compatability of 
the aldehyde and diol protecting groups. It was found 
that the conditions required to perform the isopropylidene 
(i) protection of the diol, cleaved the dimethoxy (d) and 
THP (a) protecting groups and rearranged the alkenes (e) 
and (f). The more strenuous conditions needed to remove 
the benzyl (b) and dithiane (c) moieties tended to cleave 
the diol protection (i). Eventually it was found that 
acetaldehyde (56) and the diol (129e), in the presence of 
catalytic amounts of ptoluene sulfonic acid gave the 
1,3dioxan (130eii). 	Ozonolysis of this alkene (130eii) 







The 1H NNR spectrum of the alkene (130eii) was 
complicated as the acetalisation afforded a mixture of 
diastereomers which could not be separated easily by flash 
column chromatography on silica. 	The 13C NNR spectra 
(Figure 8) were much simpler and show each of the alkene 
(130eii) carbons represented as a pair of signals 
suggesting the presence of two diastereomers in 
approximately equal proportions. 
The aldehyde (131ii) was also a mixture of 
whcJ4 
diastereomers Awere 	 - separated by flash column 
chromatography on silica. Figure 9 shows the more polar 
aldehyde (upper spectrum) and a mixture of both aldehydes 
(lower spectrum), it can be seen from the intensity of 
their Hiax protons that the diastereomers are present in. 
approximately equal proportions. 	It is notable in the 
spectrum of the more polar aldehyde that the Hiax and H 4ax 
protons are at a higher chemical shift than the respective 
protons of the other diastereomers shown in the lower 
spectrum of the mixture of aldehydes (131ii). It can be 
deduced that since the ethylidene methyl is likely to be 
equatorial (thus avoiding destabilising 1,3 diaxial 
interactions) that the more polar aldehyde (upper 
spectrum) must have an axial formyl group (increasing the 
axial proton chemical shifts) and the other diastereomer 
consequently must have an equc*torial formyl group (having 
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FIGURE 9 
The synthesis of the Wittig reagent (136) is shown in 
Scheme (29). 	Reaction of cyclohexanone (132) with 
glycolic acid (133) in the presence of pto1uene sulfonic 
acid gives the 1g 3-dioxo1an4-one (134)83 	This was 
brominated a to the carbonyl with Nbromosuccinimide to 
give the 5-bromo-1,3-dioxolan-4--one (135) 	The Wittig 
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The Wittig reaction of the aldehyde (131ii) with the 
reagent (136) gave a mixture of isomers which could be 
partially separated into two groups by flash column 
chromatography on silica. 	Figure 10 shows the 13C NMR 
spectrum (F), the 13C DEPT NMR spectrum (E) and the 1H NMR 
spectrum (B) of the more polar components. 
There are eight possible isomers in total from the 
Wittig reaction as there are two chiral centres (at C-7 
and C-4) and a double bond capable of geometric isomerism. 
It can be assumed that the C9 methyl is equatorial in the. 
product as it was equatorial in the starting material and 
is unlikely to take up the more sterically interactive 
axial position even though epimerisation is possible under 
the reaction conditions. It can also be conjectured that 
the more polar components have an equatorial methyl as the 
more polar starting material aldehyde (131ii) had an 
equatorial methyl. These assumptions would infer that the 
more polar group of isomers (spectra B., E and F) consisted 
of the pair of geometrical isomers (137i and 137ii) shown 
below. From the ratios of the H7 and H3 signals (Spectrum 








The observation that the C-7 proton (marked H7 in 
Spectrum B) appears at two different resonances is 
consistent with the assignment of an axial C-4 E and Z 
alkene substituent (i.e. equatorial C4 methyl). 	The 
observation of two olefinic resonances (marked H3 in 
Spectrum B) in the same ratio as the C-7 proton 
intensities is also consistent with the assignment of an 
axial E and Z alkene substituent. 
It is believed that the major component of the pair 
(spectrum B) is the isomer (137i) as calculation of the oH 
of the olefinic proton84 '85 suggests that a cis carbonyl 
trans oxygen configuration has a 0.1 ppm higher chemical 
shift than a cis oxygen trans carbonyl configuration. 
Geometric isoinerisation of this more polar pair by 
refluxing under U.V. in the presence of bromine afforded 
one major component. Figure 10 shows the 13C NMR spectrum 
(D), the 13C DEPT NMR spectrum (C) and the 1H NMR spectrum 
(A) of this product. 	It can be seen from the acetal 
proton integrals (H7) in the 1H NMR spectrum (A) that the 
isomers are present in the ratio of 1:10 in favour of 
previously minor component. The 13C NMR spectra (C) and 
(D) show single carbon resonances where there had 
previously been two. 	The major isomer after the Wittig 
reaction (137i) was therefore isomerised to the more 
stable isomer (137ii) on irradiation in the presence of 
bromine. 	This is consistent with model builidng 'which 
suggests that (137i) is the more crowded of the two and 
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that (137ii) is the favoured form. 
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Attempted synthesis of the diol (117) by acid 
catalysed deprotection of the diol gave a complex mixture. 
'H NMR spectra of the crude mixture showed the absence of 
the acetal quartet, indicating that the protecting group 
had been removed. However, the spectrum showed no sign of 
the characteristic pair of triplets from the -CH 2CH 20H 
fragment. It is suggested that the deprotection of this 
acetal is unsuccessful because, unlike the KDO synthesis, 
a tertiary alcohol is involved in the deprotection stage 
and the ethylidene group is more difficult to remove than 
the isopropylidene protecting group 86. These factors may 
encourage an elimination reaction to take place providing 
a conjugated diene capable of further reaction. 'In 
conclusion it would appear that the ylidene dioxolanone 
methodology is ineffective in the synthesis of the 
tetrahydropyran, (114). 
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CHAPTER 3: 	FEEDING STUDIES 
3.1 GROWTH CURVES 
Before feeding the 13C isotopically enriched 
tetrahydropyrans (63) and (99) to the bacterium Rh. 
capsulata, it was necessary to monitor both the cell and 
metabolite growth so that the tracers could be introduced 
at the optimum time for incorporation. 
Figures 11.1 and 11.2 show culture growth curves for 
anaerobic growth of Rh. capsulata on medium S. 	Cell 
growth was determined by measuring the weight of Rh. 
capsulata residue after • exhaustive acetone extraction 
(Figure 11.1) and U.V. adsorption of the culture at 600 nm 
(Figure 11.2). 	The ubiquinone10 (51) concentrations 
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The cell mass growth curves show that there is a lag 
phase of about 8 hours followed by a log phase of 20 
hours. Cell density then decreases from about fifty hours 
onwards as the cells die through lack of nutrients. The 
ubiquinone-'10 (51) production has a longer lag phase of 
about 30 hours and peaks at around 80 hours before tailing 
off. These curves indicate that the optimum innoculation 
time for feeding isotopic precursors is after about 38 
72 
hours. 	This favours incorporation of the isotopically 
enriched precursors into the ubiquinone (51) rather than 
into the cell structures formed during the log phase of 
cell mass growth. 	The optimum time for harvesting is 
about 84 hours after inoculation when the ubiquinone (51) 
concentration is at its peak. 
3.2 TYPICAL FEEDING STUDY : 13-13C1 SODIUM PYRUVATE 
A typical feeding study procedure is outlined in the 
experimental section. Figures 12.1 and 12.2 show 'C NNR 
spectra of ubiquinone-10 (51); Figure 12.2 shows natural 
abundance 13C ubiquinone-10 (51). and Figure 12,1 shows 
isotopically enriched 13C ubiquinone-10 (51) isolated from 
Rh. capsulata by preparative t.l.c. after feeding [3-13C] 
sodium pyruvate. 
The five largest peaks are due to superposition of 
eight isoprene units of the polyprenyl side chain, the 
smaller peaks are due to terminal isoprene. units and the 
quinone ring. Assignment of the polyprenyl sidechain is 
shown in Figure 12.2. The three largest saturated peaks 
at approximately a 16, 27 and 40 ppm correspond to the 
methyl (a 16 ppm) and two methylenes of the isoprene unit. 
The methylene at & 40 ppm is closest to the methyl group. 
The two largest unsaturated peaks correspond to the 
methine (a 125 ppm) and the quarternary (5 135 ppm) 
carbons of the isoprene unit. 13C assignments were based 
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(51) and comparison with the spectrum of geraniol which 
was assigned by INADEQUATE spectra82 . 
Comparing the two Figures 12.1 and 12.2, it can 
clearly be seen that the relative intensities of the five 
main peaks are different. As a measure of incorporation 
both standard and enriched spectra were normalised so that 
an arbitrary peak (one assumed to correspond to an 
unenriched carbon) was assigned as having an intensity of 
1.0. 	The normalised enriched intensities were then 
expressed as a multiple of their respective normalised 
standard intensities (see Table 4). 
3.3 FEEDING STUDY RESULTS. 
Table 4 shows the observed incorporation patterns of 
the ubiquinone-10 (51) isoprene units after enrichment 
with the precursors indicated. Table 4 also shows the 
expected alternative incorporations based on the 
condensation of pyruvate (55) with acetoacetyl-00A (14). 
[13C] sodium bicarbonate showed the same patterns as 
observed before53 (see introduction) with most of the 
label going into the C-5 position. This study showed the 
reproducibility of the result and that the isolation 
procedure was effective. 
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PREDICTED 	 OBSERVED 
PRECURSOR 	 INCORPORATIONS 	INCORPORATIONS 
NaH1 O3 	L..1,... 
1-3 
13 	 1-2 
C C _C 
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1k (4-13C] Dihydroxytetrahydropyran (63) (Table 4) showed 
the same incorporation in each of the five isoprene 
carbons. 	This can be interpreted as the result of 
breakdown of the tetrahydropyran. (63) and scrambling of 
the label before incorporation. While disappointing, the 
lack of incorporation of intact (63) does not preclude the 
intermediacy of this compound. It can for example, be 
argued that the lack of observed incorporation was due to 
lack of transport into the cell or catabolism, of the bulk 
material (for example by oxidation to mevalonic acid and 
degradation to acetyl-00A) prior to incorporation. It is 
worthy of note that if (63). is oxidised to nievalonate in 
vivo that no direct incorporation of the derived 
mevalonate occurs. This observation is consistent with 
there being no radioactivity in the ubiquinone-10 (51) 
after [2-1 C) inevalonate had been fed to Rh. capsulata as 
a control along with 13C-sodium bicarbonate (see also 
reference 53). 
To avoid the above effects, doubly enriched [4,5-'C 2 ] 
tetrahydropyran acetal (99) was fed to Rh. capsulata 
reasoning that, passive diffusion of the non polar acetal 
into the cell would produce a pool from which the hemi-
acetal (63) could be liberated by slow in vivo hydrolysis. 
This approach, of using a non-polar hydrolysable 
derivative of a biosynthetic intermediate has been used 
successfully in other studies88. Additionally, the use of 
a doubly labelled probe increases the sensitivity of the 
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experiment since it is easier to detect the presence of 
1 3C 1 3C satellite peaks, than small increases in single 
resonance intensities. 	In the event, the spectrum of 
ubiquinonelO (51) showed no 'C'C satellites and 
approximately equal incorporation of stable 13C isotope 
into all of the carbons. 	This was probably due to 
breakdown and scrambling of the label prior to 
incorporation. 
In the light of the negative tetrahydropyran results 
[3"3C] pyruvate was fed to see if it was induced in the 
isoprenoid biosynthesis in the way that had been 
hypothesised. 	It was found, like alanine (which 
deaiuinates to pyruvate) that it did not label the isoprene 
C-5 position as would have been expected in the event of 
it condensing with acetoacetyl-00A. Instead, it labelled 
the methyl position quite strongly (3.9x) and had a 
pattern of intensities similar to that for [2-13C] acetate 
(Table 1). 	It is logical to interpret this result as 
arising from pyruvate decarboxylation to acetyl-00A before 
incorporation. 
From these results it seemed clear that the postulated 
pathway, whereby pyruvate condensed with acetoacetyl-00A 
rather than a third acetate, is not involved in isoprenoid 
biosynthesis. The results however, taken in conjunction 
with the preliminary studies. (introduction), are still 
different to the normal acetoacetate pathway incorporation 
patterns and require explanation. 
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3.4 RH. CAPSULATA METABOLISM 
Rh. capsulata is capable of growth in five distinctly 
different ways: anaerobically as a photoautotroph on H 2 
and CO 2 with light as an energy source, anaerobically as a 
photoheterotroph on various carbon sources with light as 
an energy source, as a fermentative anaerobe in darkness 
on sugars as sole carbon and energy sources, 	aerobically 
as an ordinary chemotroph in darkness and aerobically as 
a chemoautotroph in darkness with H 2 as a source of 
reducing power, this gives it a varied and versatile 
metabolism89. 	Closer investigation of the metabolism 
revealed many other anomalous features relating to all of 
the precursors, that were fed. 	All of the following 
remarks are concerned with photoheterotrophic growth which 
was the standard condition for the feeding studies. 
Although Rh. capsulata photoheterotrophically uses 
light as its main source of energy it is capable of growth 
on fructose, glucose and sucrose. 	While glucose is 
catabolised via the Entner Doudoroff pathway (EDP), 
fructose is catabolised via fructose- l-phosphate and the 
Embden Meyerhoff pathway (EMP) 90 	Thus there are two 
separate pathways of sugar catabolism present in Rh. 
capsulata. 	The enzymes of the EDP are induced 
irrespective of which sugar is present whereas the EMP 
enzymes are only' induced in the presence of fructose which 
Rh. capsulata seems to prefer. 	Glucose catabolism is 
79 
regulated by glucose-6--phosphate dehydrogenase which is 
inhibited by phosphoenol pyruvate. 
The citric acid cycle, which catabolises acety1CoA 
from sugar catabolism to provide reducing power for 
oxidative phosphorylation and important biosynthetic 
intermediates 	(oxaloacetate, 	cketoglutarate 	and 
succinyl-'CoA) in aerobic metabolism appears only to be 
used as a source of intermediates in Rh. capsulata 91. It 
has been shown that o-ketoglutarate dehydrogenase, the 
regulatory catalyst in the citric acid cycle is.five times 
more active in chemotrophic than phototrophic growth and 
that even small amounts of oxygen produce large increases 
in respiratory enzymes. 
Acetate metabolism seems to be variable and strain 
dependent which may be 	a result of different micro 
environments from which various strains were isolated. 
Studies on acetate utilisation by Rh. capsulata strain St. 
Louis92 indicated that the wild type grew poorly on 
acetate. A spontaneous mutant Ad, however, Iwas found to 
be capable of vigorous and immediate growth on acetate and 
exhibited high levels of the glyoxylate cycle (see 
Appendix) enzyme isocitrate lyase. A similar situation 
has been reported for the utilisation of glycerol in Rh. 
capsulata in which two enzymes not present in the parental 
type are synthesised by a spontaneous glycerol utilising 
mutant93. It has been suggested that some of the isolates 
that had not encountered acetate or fatty acids in their 
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environment for many generations may be in the process of 
losing the ability to synthesise what would be the useless 
enzymes of the glyoxylate cycle. Some of those organisms 
may in fact have lost completely the structural genes for 
the enzymes involved while others may have retained the 
structural genes while simply losing the ability to 
express them92. 	Thus a simple explanation of the 
differences in reported Rh. capsulata glyoxylate enzyme 
compliments is that under strong selective pressure 
mutants expressing long silent genes of the glyoxylate 
cycle possess a selective advantage and are enriched in 
culture. 
The Calvin cycle (see Appendix), which incorporates 
carbon dioxide into 3-phosphoglycerate, has been shown to 
have two forms of the key enzyme (I and L) ribulose- 
1,5-diphosphate carboxylase/oxygenase (Rubisco). 	These 
enzymes are repressed by high amounts of carbon dioxide, 
the L form in particular is totally repressed by the 
amount of carbon dioxide produced on photoheiotrophic 
metabolism of malate. 	Rh. capsulata was the first 
bacterium in which two forms of Rubisco were demonstrated 
(1984)94 . 
Pyruvate as well as being metabolised to D-lactate and 
acetyl-00A has the possibility of forming ãcetaldehyde as 
pyruvate decarboxylase is present95 ' 96 . 
Alanine dehydrogenase (ADH) does not function as an 
ffl 4 assimilating enzyme, instead its function is to 
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deaminate the substrate, L-alanine, to supply the growing 
cells with the proper amount of organic carbon (i.e. 
source of pyruvate). 	However, in culture media with 
Lalanine and D,L-malate Rh. capsulata AD2 does not 
excrete NH4+ into the culture medium although the cells 
contained ADH. 	Moreover, its deaniinating capacity was 
inhibited by pyruvate (50% inhibition by 4 mM pyruvate). 
It seems that the "feedback" inhibition of the enzyme by 
C3 and C4 compounds turns off ADH activity under 
conditions where cellular nitrogen requirements can be 
satisfied by transamination of L-a1anine 9 . 
3.5 REVISED INTERPRETATION OF FEEDING STUDIES 
After close analysis of the feeding study results it 
was found that it was possible to interpret them in a way 
consistent with the acetoacetate pathway. 	The results 
that require explanation are the singly labelled acetate 
studies and the bicarbonate study. The [U13C6] glucose 
and [l,2-13C 2] acetate results are already consistent with 
the acetoacetate pathway. 
One rationalisation of the anomalously low 
incorporation of [2'3C] acetate into the C-5 isoprene 
position invokes the existence of a starter effect when 
the total amount Of enrichment in each of the three 
constituent acetate units is calculated, (i.e. C-1 and 
C2, C3 and C4, and C-5) a gradual reduction from the 
first to the third (C-1 and C-2 to C-5) is observed. This 
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effect is essentially a dilution of the label and occurs 
as a result of the amount of time it takes for the latter 
units to be incorporated. 	That is, the longer the 
isotopically enriched acetate remains in the cell the 
greater its chance of being randomly incorporated and the 
lower its chance of being incorporated into ubiquinone-10 
(51). The observed C-5 isoprene 13C NMR intensity might 
therefore constitute a low incorporation rather than none 
at all. This starter effect would also be enhanced by the 
poor utilisation of. acetate by Rh. capsulata and would 
explain how the observed result could be consistent with 
the biosynthesis via the acetoacetate pathway. 
In an attempt to overcome this starter effect and 
encourage incorporation of isotope into the isoprene C-5 
position, [2 13C] acetate was fed together with lithium 
àcetoacetate. It was hoped that the lithium acetoacetate 
would form a pool of acetoacetylCoA with which the 
[2 13C] acetate would condense rather than condensing with 
itself to form [2,4'3C 2] acetoacetyl-00A. In the event, 
the pattern of incorporation was very similar to that 
obtained .with (2-13C] acetate alone. This could have been 
due to random metabolism of acetoacetate or slow formation 
of acetoacetylCoA. 
The high level of enrichment in the isoprene C-5 
position after ['SC] sodium bicarbonate feeding can also 
be explained by a time lag in metabolism. 	[ 1 C] Sodium 
bicarbonate is incorporated into the C-3 position of 
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glucose-6-phosphate via the C-i of 3-phosphoglycerate in 
the Calvin cycle. Glucose-6-phosphate is then metabolised 
via the Entner-Doudoroff pathway to [3-13C] pyruvate and 
to [2-13C] acetyl-00A by oxidative decarboxylation of 
pyruvate. It is suggested that by the time the bacterium 
has metabolised the [ 13C] sodium bicarbonate to [2-13C] 
acetyl-00A it has already built up a pool of natural 
abundance acetoacetyl-00A with which the [2-13C] 
acetyl-CoA condenses. This mechanism would explain how 
the [ 13C] sodium bicarbonate and [l-'C] acetate (which 
loses its 13C label in the form of carbon dioxide via the 
Kreb's cycle) results could be consistent with 
biosynthesis via the acetoacetate pathway. 
Proving that the acetoacetate pathway exists in Rh. 
capsulata using feeding studies is made difficult by the 
varied metabolism it exhibits. 	It may be possible to 
prove its existence by monitoring the label using 13C NMR 
as it moves through the metabolite pools. However, a more 
direct way would be to assay for the acetoacetate pathway 
enzymes. From the existence of these enzymes one could 
invoke the use of the acetoacetate pathway in isoprenoid 
biosynthesis. 
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CHAPTER 4: 	ENZYMOLOGY 
4.1 INTRODUCTION 
The initial precursor feeding studies, as described 
previously (Introduction part 6) had suggested that the 
Rh. capsulata isoprenoid pathway might possibly involve 
pyruvate condensation with acetoacetyl-CoA rather than a 
normal acetyl-00A, acetoacetyl-CoA condensation. Feeding 
studies with the [5- 13C] dihydroxytetrahydropyran (63) and 
the 	(5,6-13C 2] hydroxymethoxytetrahydropyran (99) seemed 
to disfavour this hypothesis and a revised interpretation 
of the feeding studies as a whole with respect to the 
metabolism of Rh. capsulata seemed to suggest the use of 
the classical acetoacetate pathway. 
To resolve these apparent contradictions it was 
decided to investigate whether specific enzymes of the 
acetoacetate pathway were present in Rh. capsulata. The 
enzyme 3-hydroxy- 3methylglutaryl-00A (HMGC0A) synthase 
was selected for investigation. Although it is the key 
enzyme involved in the condensation of acetyl-00A and 
acetoacetyl-CoA, HMGC0A synthase activity has not 
previously been detected in bacteria. 	The enzyme was 
originally discovered in bakers yeast98 and shown to 
catalyse the reaction of acetyl C0A (13) with 
acetoacetyl-CoA (14) shown in Scheme 1. 
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While it is recognised that the bacterial enzyme, 
should it exist, might possess different properties (with 
regards to solubility, Km etc.) to the eukaryotic HNGCOA 
synthase, it was decided to repeat the work of Middleton 
and Tubbs25 for the assay of this enzyme in yeast and 
having successfully repeated this work to apply the 
methodology directly to Rh. capsulata. 
Figure 13 shows the previously described 25 assay 
system. The principle of this spectrophotoinetric assay is 
based on the absorption of the enol form of acetoacetyl- 
00A at 303 nm. 	The synthase activity is measured by 
observing the acetyl-00A stimulated decrease in 
absorption. The protein determination was carried out by 
Bradford microassay procedure which is described in detail 
in the experimental section along with the full 
description of the assay procedure. 
The observed rate was converted to specific activity 
and compared with the specific activity obtained by 
Middleton and Tubbs. The respective specific activities 
after ethanol ic-fractionation of the bakers yeast lysate 
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It should be noted that Ferguson and Rudney 98 have 
observed that erroneously high activities can be observed 
as a result of the presence of non specific thiolase 
Activity. To obtain the correct HMGC0A synthase rate, the 
thiolase rate was first determined by observing the 
decrease in absorption when only acetoacetyl-00A was 
present in the cuvette with the enzyme solution. This 
thiolase rate was then subtracted from the rate of 
acetoacetyl-CoA disappearance after acetyl-00A addition. 
Typical thiolase rates were of the order of 0.08 
absorbance unit min' and all rates quoted here have been 
corrected for. thiolase activity. It should be noted that 
this adjustment does not 'take into account any loss of 
acetyl C0A from thiolysis. 
To confirm the presence of HMGC0A synthase in yeast 
the cells were lysed by another more gentle method used 
routinely in the preparation of yeast mitochondria 99 
outlined in Figure 14 	This method involves hand 
honiogenisatiori of sphaeroplasts obtained from the action 
of xyinolase on the cells. Table 5 shows the result of the 
assay on the supernatant (1) after centrifugation of the 
cell homogenate and supernatant (2) after homogenisation 
of the pellet and centrifugation. The specific activities 
were calculated as before and are corrected for thiolase 
activity. 
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Rate 	Protein 	Activity 
(min-') 	(iugml') 	(units mg-1 ) 
Supernatant 1 	0.035 	4.45 	 0.045 
Supernatant 2 	0.028 	2.15 	 0.065 
Table 5 
These results confirm the presence of HNGC0A synthase 
in yeast at a specific activity of the order of that 
observed by Middleton and Tubbs after ethanolic 
fractionation of bakers yeast. The thiolysis rates were 
much lower in this preparation accounting for 
approximately one fifth of the observed rate as opposed to 
approximately one quarter from the other preparation. 
4.2 RH. CAPSULATA HMGC0A SYNTHASE ASSAY 
To disrupt the cells of Rh. capsulata the subcellular 
preparation developed by Cox, Beatty and Flavinger91 was 
used, this preparation is outlined in Figure 15. 












cell homogenate 	 > Assay 1 
20000g/15 mm 
V 
2 Assay <- pellet 	supernatant 	-> Assay 3 
(cell debris) (cytoplasm) 
150000g/90 mm 
V 
5 Assay <- 	pellet 	supernatant -> Assay 4 
(membranes) (cytoplasm) 
phosphate buffer.  
150000g/90 mm 
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It was decided to assay for succinate dehydrogenase as 
well as HNGC0A synthase from this preparation as it would 
ensure that the preparation was carried out effectively 
(Cox, Beatty and Flavinger determine succinate 
dehydrogenase activity using this preparation) and it 
would give some information on the location of HMGC0A 
synthase in the cell. Succinate dehydrogenase was shown 
to be membrane bound and not in the cytosol of Rh. 
capsulata9 1 
It should be noted that in chicken liver (eukaryotes) 
HNGC0A synthases are found both in the cytosol'°° and in 
the mitochondria24 where their distinctly different 
properties are found to be consistent with the independent 
regulation of cholesterogenesis and ketogenesis 
respectively. 	It is therefore not possible to predict 
solubility etc. of the bacterial protein which may be 
soluble (cytosolic) or bound to some membrane fraction. 
The assay method used for succinate dehydrogenase was 
based on a method of King' 0' as developed by Owen and 
Freer'02. Succinate was used as a substrate along with 
potassium cyanide as an inhibitor of the terminal oxidase, 
phenazine methosulphate (PMS) was used as the intermediate 
electron acceptor and dichlorophenolindophenol (DCPIP) as 
terminal electron acceptor. 	The activity of succinate 
dehydrogenase was measured by the decrease in absorption 
at 600 nm of DCPIP. 	Figure 16 shows the cascade of 
electron transfers with PMS as the intermediate electron. 
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acceptor, which results in the oxidative decolouration of 
the DCPIP dye. 	The precise mechanisms of succinate 
oxidation by ferricyanide and PMS are not known although 
it can be presumed that oxidation occurs via a series of 
one electron transfer steps. 






CH3 	 CH3 
1)IjcH3so;+H)~(H) 
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(cH3so; + H) 
FIGURE 16 
Table 6 shows the thiolase corrected rates, protein 
concentrations and specific activities of the various 
stages of the preparation (Figure 15). 
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HMGC0A 
HMGCoA Succinate Synthase 
Synthase Dehydrogenase Protein Specific 
Rate Rate conc. Activity 
(min') (min-') (ingml 1 ) (units mg') 
1 cell 
homogenate 0.0064 2.65 0.0120 
2 cell debris 0.0037 18.25 0.0010 
3 cell 
supernàtant 0.0040 27 0.0074 
4 cytosol 0.0023 0 6.0 0.0019 
5 membranes 0.0010 0.00473 6.6 0.0007 
6 membranes 
(washed) 0 2.2 0 
7 washings 0.0020 6.9 0.0014 
1 cell 
homogenate 
(after 3 hrs) 0.0047 2.65 0.0090 
Table 6 
These results show several important features: 
HNGC0A synthase exists in Rh. capsulata and is present 
mainly in the cytosol. 
Succinate dehydrogenase is present in Rh. capsulata 
and is completely membrane bound. 
Rh. capsulata HNGC0A synthase is probably not present 
in the membranes although this negative result may be 
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due to cleavage of the enzyme by peptidases. 
Rh. capsulata HMGCoA synthase is unstable. Activity 
decreases by u 25% in three hours at RT. 
Rh. capsulata HMGC0A synthase has no affinity for 
pyruvate as its addition made no change to the rate. 
In conclusion, it appears likely that isoprenoids are 
biosynthesised by the classical acetoacetate pathway in 
Rh. capsulata. To further confirm this theory the assay 





All starting materials were purchased from commercial 
sources mainly Aldrich, Fluka and Sigma. Reagents were 
routinely redistilled or recrystallised before use. The 
following solvents were dried using the reagents given in 
parenthesis 	before 	distillation:- 	chloroform, 
dichloromethane, ethyl acetate (calcium chloride); 
ethanol, methanol (magnesium sulphate); diethyl ether, 
tetrahydrofuran, 1, 2-dimethoxyethane (lithium aluminium 
hydride); toluene, benzene (sodium); ethyl formate 
(phosphorous pentoxide). 
Merck Kieselgel 100 (70-230 mesh) silica was used for 
flash column chromatography. Thin layer chromatography 
(t.l.c.) was carried out on 20x2Ocm glass sheets precoated 
with Merck Kieselgel 60 silica. 	Solvent systems were 
either ethyl acetate/hexane (1:1) or chloroform/methanol 
5% unless otherwise stated. 	Visualisation of the 
components was achieved by either: iodine vapour, UV 
absorption at 254 nm or phosphomolybdic acid spray. High 
pressure liquid chromatography (HPLC) was carried out 
using a Gilson 303 pump and 802 manometer, a LDG 1203 UV 
III monitor and a BCG Goerz servoger 210 printer. 
Infra red spectra were recorded on a Perkin Elmer 781 
spectrophotometer using the polystyrene 1603 cm' peak as 
a standard. Solid samples were tested as nujol mulls and 
oils were tested as thin films. 
Electron Impact (El) mass spectra were recorded on an 
AEI MS902 spectrometer. Fast atom bombardment (FAB) and 
chemical ionisation (CI) spectra were recorded on a Kratos 
MS50TC spectrometer.  
Proton nuclear magnetic resonance (NMR) spectra were 
recorded on either a Bruker WP80 (80 MHz), WP200 (200 MHz) 
or WH360 (360 MHz) spectrometer in the solvent indicated 
using tetramethylsilane (TMS) (o 0.0) as an external 
standard. Carbon 13 NMR spectra were recorded on either a 
Bruker WP200 operating at 50.3 MHz or a Bruker WP360 
operating at 90 MHz using CDC1 3 as an internal standard (a 
77.0 ppm). 
Melting points were recorded on an electrically heated 
Reichert 7905 melting point apparatus and are uncorrected. 
2 HYDROXYTETRAHYDROPYRAN (82): - 
2,3-Dihydropyran (81) (168 ml : 155g : 1.84 mol) was 
added slowly to a stirred, ice cooled, solution of water 
(300 ml) and conc hydrochloric acid (25 ml). 	The 
temperature was maintained below 37°C and the reaction ran 
for i hour. The mixture was neutralised using 5N sodium 
hydroxide (phenolphthalein indicator) until a faint pink 
colour remained, and then continuously extracted with 
ether for 20 hours. The extract was dried with magnesium 
sulphate, filtered, evaporated and distilled through a 
vigreux column to give a clear colourless oil (125.5 g, 
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67%); b.p. 66-69°C (1-3 mm Hg) (lit. 50-52°C, 0.7 mm Hg); 
6H(CDC13, 80 MHz), 1.37(6H, m, 3xCH 2), 340(1H, rn, CH), 
3.80(1H, m, CH), 4.75(1H, bs, OH), 4.75(1H, m, CH); 
E.I.M.S. m/z 101(M_1)+,  85, 86, 43. 
1- (TETRAHYDROPYRANYL-2-OXY) -BUTAN-3--ONE (74):-
Methyl vinyl ketone (83) (70.0 g, 83 ml, 1 mol) was 
added over 3/4 hour to a stirred solution of 2-hydroxy- 
tetrahydropyran (82) (102 g, 1 mol) 	and inethanolic 
potassium hydroxide (3N) (4.00 ml) at -5°C. The mixture 
was stirred at below 5°C for 2 hours and room temperature 
for 1i hours. 	The mixture was then neutralised using 
hydrochloric acid (2N) (phenolphthalein indicator), 
diluted with ether (400 ml) and dried over sodium sulphate 
before being evaporated and distilled to give a clear 
colourless oil (115.8 g, 67%); b.p. 77-83°C, 2 mm Hg 
(lit . 110°C, 13 mm Hg); 6H(CDC131 80 MHz), 1.37(6H, m, 
3xCH 2 ) 1 1.95(31!, s, Me), 2.47(2H, t, J=5H, CH 2), 
3.2-3.9(4H, ni, 2xCH), 4.35(11!, m, CH); vmax(thin film), 
1720 cm- 1 (C=O); ElMS in/z 171(M_1)+,  127, 99, 85, 71, 55, 
43. 
1- (TETRAHYDROPYRANYL-2 -OXY) -3 -HYDROXY-3 -METHYLHEX-5-ENE 
(84):- 
Allyl bromide (3.62 g, 30 luniol) and 4-(tetrahydro- 
pyranyl-2 -oxo) -butan-3 -one (74) (3.44 g, 20 inmol) in dry 
tetrahydrofuran (40 nil) were added to magnesium turnings 
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(0.96 g, 40 inmol) under nitrogen at such a rate that the 
mixture ref luxed gently. 	After a further 3 hours 
ref luxing, the mixture was cooled, diluted with water (40 
ml), relieved of excess magnesium via a sieve and 
acidified with conc. sulphuric acid (2 ml). The solution 
was then extracted with ether (3 x 50 ml) and the extract 
washed with saturated sodium bicarbonate (50 ml), dried 
over magnesium sulphate, filtered and evaporated to give a 
clear colourless oil. 	Purification by flash column 
chromatography on silica gave a clear colourless oil (2.18 
g, 50%); b.p. 102-106°C, 1 mm Hg; 6H(CDC13,  80 MHz), 
1.10(3H, 5, Me), 1.50(8H, bin, 4xCH 2), 2.35(2H, d, J=7Hz, 
CH 2), 3.1(1H, bs, OH), 3.3-4.1(4H, m, 2xCH 2), 4.5(lH, bs, 
CH), 4.9(1H, in, CH), 5.05(1H, m, CH), 5.5-6(1H, in, CH); 
FABMS m/z 215.16473 (MH+ CH12H2303 requires 215.16471), 
ElMS 173, 101, 85, 43; Found: C, 67.3; H, 10.6 requires C, 
67.3; H, 10.3% along with 1,3-dihydroxy-3-methylhex-5-ene 
(71) (0.58 g, 22%); b.p. 85-87 1 nun Hg (lit. 175-180°C, 20 
mm Hg); 6H(CDC13,  80 MHz), 1.20(3H, 5, Me), 1.70(2H, td, 
J=6Hz, 2Hz, CH2), 2.30(2H, d, J=7Hz, CH 2), 3.40(2H, bs, 
2xOH), 3.85(2H, t, J=6Hz, C!!2), 5.0(1H, in, CH), 5.2(1!!, m, 
CH), 5.6-6.1(1H, in, CH); FABMS m/z 131.10721 (MH C 7H1502 
requires 131.10720); FABMS m/z 131(MH+),  102, 94. 
1,3-DIHYDROXY-3-METHYLHEX-5-ENE (71) :- 
1- (tetrahydropyranyl-2-oxo) -3-hydroxy-3-inethylhex-5-
ene (84) (626 mg, 3 inmol) was stirred in a mixture of 
kE 
ethanol (15 ml) and hydrochloric acid (2N) (1 ml) at 50°C 
for 20 minutes. The mixture was then neutralised with 
sodium hydroxide (5N) (phenolphthalein indicator), dried 
over magnesium sulphate, filtered, evaporated and purified 
by flash column chromatography on silica gel to give a 
clear colourless oil (280 mg, 73%). The product was tic, 
NNR and b.p. homogeneous with a standard sample. 
2, 4-DIHYDROXY-4-METHYLTETRAHYDROPYRAN (63):- 
A solution of 1,3-dihydroxy3-iuethyi-5-ene (71) 
(280 mg, 2.15 imnol) in methylene chloride (25 ml) was 
subjected to ozonolysis for i hour at -78°C. Triphenyl-
phosphine (676 mg, 1.2 eq, 2.58 inmol) was added and the 
mixture allowed to warm up to room temperature overnight. 
The solvent was removed and the residue purified by flash 
column chromatography on silica gel to give a mixture of 
diastereomers as a clear colourless oil (230 mg, 90%), 
b.p. 	80°C 	1 mm Hg dec., 	6H(CDC13 1 	360 MHz), 
1.18-1.25(6H, 	in, 	2xCH3 )
1 	1.28-1.82(8H, 	in, 	4xCH 2 ) 1  
2.0-2.25(2H, bs, 2xCH), 3.48-4.25(6H, in, 2xCH + 2xOH), 
4.9-5.25(2H, m, 2xCH); 6c(CDC13, 50 MHz), 30.2(Me), 
37.9(C4), 41.O(C2), 55.6(C5), 68.0(C3), 92.1(d); and 
30.9(Me), 	37.8(C4), 	45.2(C2), 	61.2(C5), 	69.2(C3), 
93.0(d); CIMS in/z 133(MH+),  131, 115, 98; FABMS m/z 
132.078643 (M C 6H1203 requires 132.07864). 	One of the 
diastereoxners was obtained in sufficient purity to assign 
its proton coupling constants (CDC13, 360 MHz), 1.20(3H, 
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s, Me), 1.54(1H, ddddd, 24eq4ax. = 	13.7HZ, 4 4eq,5ax = 
2.8Hz, 44eq2eq = 2.6Hz, 34eqseq = 2.0Hz, 5J4eqieq = 
0.7HZ, H4EQ), 1.65(1H, dd, 22ax2eq = 14.0Hz, 3 2axieq = 
3.5Hz, H2AX), 1.70(1H, ddd, 24ax4eq = 13.7Hz, 3 4ax5Ax = 
12.4Hz, 34ax5eq = 5.3Hz, H4AX), 1.79(lH, ddd, 2 2eq2Ax = 
14.0Hz, 42eq4eq = 2.6Hz, 	2eq5ax = 0.6Hz, H2EQ), 
2.25(1H, bs, OH), 3.6.1(1H, dddd, 2seq5ax = 11.9Hz, 
35eq4ax = 5.3Hz, 3J 5eq4eq = 2.0Hz, 4J seqieq = 0.4Hz, 
H5EQ), 3.68(2H, bs, 2xOH), 4.17(1H, dddd, 35ax4ax = 12.4 
Hz, 2saxseq = 11.9Hz, 35ax4eq = ,8HZ, 55ax2eq = 0.6HZ, 
H5AX), 5,22(lH, ddd, 31eq2ax = 3.5Hz, 4ieqseq = 0.4Hz, 
H1EQ). 	The average ratio of the intensities of the 
isomerically equivalent carbon atoms in the 13C  spectrum 
was 3:10 with the isomer described in detail above being 
the major component. 
METHYL-3- (TETRAHYDROPYRAMYL-2OXY)-PROPANOATE (86 
Methyl acrylate (85) (50 g, 5.0 ml, 60 mmol) was added 
to a stirred solution of 2-hydroxytetrahydropyran (82) 
(5.1 g, 50 mmol) and methanolic potassium hydroxide (3N) 
(0.2 ml) at 50°C over 1 hour. A further portion of methyl 
acrylate (2.5 ml, 30 mmol) and methanolic potassium 
hydroxide (3N) (0.2 ml) were added and the reaction left 
to stir at 50°C for another hour. 	Finally, methanolic 
potassium hydroxide (3N) (0.2 ml) was added and after 
hour when the solution was neutral the excess methyl 
acrylate was evaporated off and the residue purified by 
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flash column chromatography on silica gel to give a clear 
colourless oil (6.8 g, 73%); b.p. 69-71°C 1 mm Hg; 
6H(CDC1 3 1 200 MHz), 1.50(6H, m, 3xCH 2 ), 2.53(2H, t, 
3J=6.4Hz, CH 2), 3.63(3H, s, Me), 3.3-4.2(4H, m, 2xCH 2 ) 1  
4.56(1H, m, CH); vax(thifl film) 1745 cm-1 (C=O); FABMS 
m/z 189.11268 (MH+ C 9H1?04 requires 189.11267); FABMS m/z 
189(MH+), 85. 
3-(TETRAHYDROPYRANYL-2-OXY) -PROPANOIC ACID (87):-
The esters (86) (1.14 g, 6 mmol) was stirred at 60°C 
in 10% sodium hydroxide (10 ml) for 2 hours then diluted 
with water (10 ml) and stirred for a further 2 hours at 
60°C. The solution was then extracted with ethyl acetate, 
acidified with hydrochloric acid (2N) to pH 4-5 and 
extracted again with ethyl acetate. The extract was dried 
over magnesium sulphate, filtered, evaporated and purified 
by flash column chromatography on silica gel to give a 
clear colourless oil (894 mg, 86%); b.p. 96-99°C, 1 mm Hg; 
6H(CDC13 1 60MHZ), 1.67(6H, in, 3xCH 2), 2.33(2H, t, 3J=6Hz, 
CH 2), 3.0-4.1(4H, in, 2xCH 2), 4.31(lH, bs, CH), 10.1(H, bs, 
OH); i'max(thin film) 1650 (C=O) 3400 cm' (OH); FABMS m/z 
175.09702 (MH+ C8H1504 requires 175.09703); FABMS m/z 
175(MH)., 157, 101, 85. 
ATTEMPTED PREPARATION OF 1- (TETRAHYDROPYRANYL-2-Oxy) - 
BUTAN-3-ONE (74) :- 
The acid (87) (474 mg, 2.75 imnol) in dry 
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diinethoxyethane (2 ml) was added dropwise over 10 minutes 
to a stirred solution of lithium hydride (26 mg, 3.2 imuol) 
in dimethoxyethane (2 ml). The mixture was then refluxed 
for 2 hours, before the then bright pink suspension was 
cooled (ice bath) and an ethereal solution of methyl 
lithium (2.28 ml of 1.4M soln., 3.2 mmol) added. 	The 
mixture was stirred at room temperature overnight before 
being diluted with water (8 ml), acidified to neutrality 
with hydrochloric acid (2N, 3m1) and extracted with ether. 
The extract was dried over magnesium sulphate, filtered 
and evaporated to give a complex oil (229 mg) the bulk of 
which was t.1.c. homogeneous with 2-hydroxytetrahydropyran 
(82). 
1- (TETRAHYDROPYRANYL-2-OXY) -PROPAN-3-OL (89): 
Dihydropyran (81) (54.74 ml, 50.5 g, 0.6 mnol) was 
added to a solution of propane-1,3-diol (88) (36 ml, 38 g, 
0.5 muol) and dry methylene chloride (400 ml) along with 
p-toluenesulfonic acid (1.9 g, 0.01 mnol) at 0°C under 
nitrogen and stirred for 1.5 hours. 	Solid sodium 
bicarbonate (35 g) was added, and the solution filtered 
through a plug of Celite before being evaporated to give a 
yellow oil (90 g). Purification of this crude mixture (5 
g) by silica flash column chromatography gave a clear 
colourless oil (1.65 g, 37%); bp. 62-64°C, 1 mm Hg; 
5H(C13 , 60 MHz), 1.60(6H, bin, 3xCH 2 ) 1  1.80(2H, mu, Cl!2 ), 
264(lH, bs, OH), 3.3-4.1(6H, bin, 3xCH 2 ), 4.53(lH, bs, 
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CH); FABMS m/z 161.11777(MH+ C8H1?Oa requires 161.11776); 
ElMS m/z 159(M_1+)  101, 85. 
1-(TETRAHYDROPYRANYL-2-OXY) -PROPAN-3-OL (89):-
The ester (86) (1.7 g, 9 mmol) in dry tetrahydrofuran 
(10 ml) was added to a suspension of lithium aluminium 
hydride (684 mg, 18 mmol) in tetrahydrofuran (40 ml). The 
mixture was stirred under nitrogen at room temperature and 
refluxed for 1 hour each before water (0.76 ml), 10% 
sodium hydroxide (1.14 ml) and water (.2.28 ml) were added 
in succession. After stirring for a further 15 minutes 
the mixture was diluted with ether (100 ml) and filtered. 
The filtrate was then dried over magnesium sulphate, 
filtered, evaporated and purified by flash column 
chromatography on silica gel to give a clear colourless 
oil (960 mg, 67%). The product was t. 1.c., NNR and b.p. 
homogeneous with a standard sample. 
1 (TETRAHYDROPYRANYL-2-OXY) -PROPAN-3-AL (90):-
The alcohol (89) (1.46 g, 9 mmol) was stirred with 
pyridinium chlorochromate (3.25 g, 15 mmol), sodium 
acetate (120 mg, 1.5 mmol) and dry methylene chloride (35 
ml) at room temperature for 1 hour. The reaction mixture 
was diluted with ether and filtered through a silica plug 
before flash column chromatography on silica gave a clear 
colourless oil (600 mg, 42%); 	b.p 48-51°C 1 mm Hg; 
6H(CDC1 3, 60 MHz), 1.67(6H, m, 3xCH 2), 2.71(2H, td, 
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3J=6.2Hz, CH 2), 3.2-4.3(4H, in, 2xCH 2), 4.63(1H, bs, CH), 
9.82(1H, t, J=2Hz, CHO); Pmax(thifl film) 1725 cm' (C=O); 
FABMS m/z 159.10210(MH+ C8H1503 requires 159.10211); 
FABMS m/z 159(NH), 102, 87, 47. 
1- (TETRAHYDROPYRANYL-2-OXY) -BUTAN-3-OL (91):-
The. aldehyde (90) (600 mg, 3.8 mmol) in dry ether 
(5 ml) was added to a stirred solution of magnesium (91 
mg, 308 mmol), iodomethane (0.24 ml, 540 mg) and ether (5 
ml) under nitrogen. The mixture was refluxed for 1 hour 
before being allowed to cool and then acidified with 
ammonium chloride (satd., 50 ml). The mixture was then 
extracted with ether and the extract dried over magnesium 
sulphate, filtered, evaporated and purified by flash 
column chromatography on silica gel to give a clear 
colourless oil (216 mg, 33%); b.p. 61-63°C 0.5 mm Hg; 
6H(CDC1 3, 60 MHz), 1.2(3H, d, J=7Hz, CH 3), 1.67(6H, in, 
3xCH 2 ) 1  1.73(2H, in, CH), 3.2(lH, bs, OH), 3.2-4.2(5H, in, 
2xCH 2 + CH), 4.55(lH, bs, CH); FABMS m/z 175.133411 (MH+ 
C 9H1903 requires 175.133410), ElMS m/z 173(M_1+), 129, 
101, 85, 73, 45. 
1- (TETRAHYDROPYRANYL-2-OXY) BUTAN-3-ONE (74):-
The alcohol (91) (2 10 mg, .1.2 mmol) was stirred with 
pyridinium chlorochromate (388 mg, 1.8 mmol), sodium 
acetate (15 mg, 0.18 mmol) and dry methylene chloride 
(5 ml) at room temperature for 3 hours. 	The reaction 
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mixture was diluted with ether (20 nil), filtered through a 
silica plug, evaporated and purified by flash column 
chromatography on silica gel to give a clear colourless 
oil (144 mg, 70%). The product was t.l.c., NNR and b.p. 
homogeneous with a standard sample. 
1 ,lDIMETHOXYBUTAN-3-ONE (97):-
Anhydrous ethyl formate (96) (0.62 g, 10.3 nimol) and 
acetone (0.5 g, 8.6 imnol) in anhydrous ether (2 ml) were 
added dropwise to a stirred suspension of sodium methoxide 
(0.47 g, 8.6 inmol) in anhydrous ether (5 ml) under 
nitrogen. The reaction mixture was then refluxed for 1 
hour, cooled and the ether carefully removed at aspirator 
pressure. Methanol (2.06 ml, 1.65 g, 51.5 mmcl) was added 
to the residue and the suspension stirred for a few 
minutes before the addition of niethanolic hydrogen 
chloride (17.4 mmol, 1.2 ml of a 15M soln.). 	After 2 
hours at room temperature the pH was adjusted to 8 by 
addition of saturated methanolic potassium hydroxide 
Ether (5 ml) was added and the mixture filtered, the 
filtrate concentrated on a rotary evaporator and the 
residue redissolved in ether. The mixture was once again 
filtered and evaporated, (care was taken to avoid loss of 
product by prolonged evaporation) and the residue was 
distilled via a short path condenser using liquid nitrogen 
to cool both flasks (receiver and reaction) before 
applying a high vacuum. After 1 hour the distillate was 
106 
dissolved in ether and left over Linde sieve 4A and sodium 
sulphate to remove methanol and water. 	The ether was 
finally evaporated off to give a clear colourless oil (160 
mg, 14%); b.p. 6264°C 760 mm Hg; (lit;' 2. 64°C); 6H(CDC13 1 
60 	MHz), 2.1(3H, s, CH 0., 2.68(2H, d, 3J=7Hz, CH 2), 
3.3(6H, s, 2xCH3 ) 1  4.72(].H, t, 3J=7Hz, CH) ; Pmax(thin 
film), 1720 cm' (C=O); ElMS 101, 85, 75, 43, 32, 31. 
ETHYL 3-HYDROXY3METHYL-5.5DIMETHOXY PENTANOATE (98) :- 
To diisopropylamine (7 ml, 50 g, 50 mmol) in dry 
tetrahydrofuran (150 ml) at 78°C under nitrogen was added 
butyllithium (32 ml of 1.6M soin,, 50 mmol) over 10 
minutes and the mixture allowed to warm up to 0°C. The 
mixture was recooled to 78°C, ethyl acetate (4.9 ml, 
4.4 g, 50 mmol) added slowly and the mixture stirred at 
78°C for 	hour. 	Acetoacetaldehyde dimethyl acetal 
(6.7 ml, 6.6 g, 50 mmol) was added and the mixture left at 
78°C and room temperature for 	hour each before 
saturated ammonium chloride (75 ml) was added and the 
tetrahydrofuran evaporated. 	The residue was extracted 
with ether, washed with brine, dried over magnesium 
sulphate filtered and evaporated to give a clear 
colourless oil (7.6 g, 67%), b.p. 98-100°C 0.5 mm Hg (lit. 
70°C, 0.01 mm Hg), ÔH(CDC13,  60 MHz), 1.2(3H, s, Cl!3), 
(3H, t, 3J=7Hz, Cl!3), 1.8(2H, d, 3J=7Hz, Cl!2), 2.43(2H, s, 
CH 2), 325(6H, s, 2xOCH 3), 3.85(lH, bs, OH), 4.1(2H, q, 
3J=7Hz), 4.5(lH, t, J=7Hz, CH); vmax(thifl film) 1735 
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(C=O), 3400 cm' (OH); FABMS m/z 189(M_31+),  171, 131. 
1 • l-DIMETHOXY-3 , 5-DIHYDROXY-3-METHYLPENTANE (751:- 
A solution of the ester (98) (7.13 g, 32 mmcl) in dry 
tetrahydrofuran (50 ml) was added to a suspension of 
lithium aluminium hydride (2.43 g, 64 mmol) in 
tetrahydrofuran (100 ml) and the mixture refluxed for 1 
hour. Water (2.43 ml), 10% sodium hydroxide (2.43 ml) and 
water (7,3 ml) were added in succession and the mixture 
was filtered, dried with magnesium sulphate, filtered, 
evaporated and purified by flash column chromatography on 
silica gel to give a clear colourless oil (5.3 g, 92%); 
b.p. 103-105°C, 1 mm Hg; 611(CDC1 3, 60 MHz), 1.2(3H, s, 
CH 3), 1.8(2H, d, 3J=7Hz, CH.), (1.8, t, 3J=7Hz, CH 2), 
3.25(6H, 5, 2xOMe), 3.7(2H,. t, 3J=7Hz, CH 2), 4.5(111, t, 
3J=7Hz, CH); FABMS m/z 179.12831 (MH C8H 1904 requires 
179.12832), ElMS m/z 133, 115, 101, 75. 
2 -METHOXY-4-HYDROXY-4 -METHYLTETRAHYDROPYRAN (99):- 
The diol (75) (534 mg, 3 mmcl) was stirred at room 
temperature in dry methanol (10 ml) along with AG50 WX2 
acidic ion exchange resin (1 g) for 1 hour. The resin was 
filtered off and washed with methanol. The washings and 
filtrate combined were evaporated and purified by flash 
column chromatography on silica gel to give two clear 
colourless oils (75 mg, 17%); b.p. 60-62°C 8 mm Hg; 
Rf(hexane/ethylacetate 1:1)=0.5; 6H (CDC13, 360 MHz), 
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1.17(1H, S, 	CH 01 	]..54(1H, 	ddddd, 	24eq4ax 	= 13.6HZ, 
34ex5ax = 	2.7Hz, 	44eq2eq 	= 2.5HZ, 3j 4eq5eq = 	1.7Hz, 
5j 4eqieq 0.8Hz, 	H4EQ), 	1.7(1H, 	dd, 	22ax2eq = 	14.1HZ, 
32axieq = 	3.6Hz, 	H2AX), 	1.7(1H, 	ddd, 	234ax4eq = 	13.6Hz, 
34ax5eq = 5.3Hz, 3j4ax5ax = 12.7Hz, 	H4AX), 	1,78(1H, dddd, 
22eq2ax = 	14.1Hz, 	4j2eq4eq 	= 2.5Hz, 	32eqieq = 	1.6Hz, 
52eq5ax = 	0.6Hz, 	H2EQ), 	3.37(3H, 	S, 	OM), 	3.6(1H, 	dddd, 
2seqsax = 	11.8Hz, 3j5eq4ax 	= 5.3Hz, 	35eq4eq = 	1.7Hz, 
45eqieq = 0.6Hz, 	H5Eq), 	3.94(1H, 	dddd, 	2sax5eq = 1.8Hz, 
35ax4ax = 	12.7Hz, 3j5ax4eq 	= 2.7Hz, 	55ax2eq = 	0.6Hz, 
H5AX), 	4.04(111, bs, 	OH), 	4.79(1H, 	dddd, 	3ieq2ax = 3.6Hz, 
ieq2eq = 	1.6Hz, 	5ieq4eq 	= 0.8Hz, 	4ieqseq = 	0.6Hz, 
H1EQ) 	oc(CDC13,  50 	MHz), 29.8(Me), 	37.9(C4), 40.9(C2), 
54.9(C5),, 55.7(OMe), 	66.5(C3), 	98.8(d) 	and 	(245 mg, 	56%); 
b.p. 	= 46-49°C, 	0.75 mm Hg; Rf(hexane/ethyl acetate 1:1)= 
0.3; 	6H(CDC13, 	360 	MHz), 	1.27(3H, 	s, 	Me), 	1.50(1H, 	dddd, 
4eq4ax = 	13.7Hz, 	3j 4eq5eq 	= 4.0Hz, 3j 4eqsax = 	3.2Hz, 
44eq2eq = 	1.9Hz, 	H4EQ), 	1.51(1H, 	ddd, 	22ax2eq = 	13.4Hz, 
32axlax = 	7.8Hz, 	42ax4ax = 	0.8Hz, 	H2AX), 	1.63(1H, ddd, 
34ax4eq = 	13.7Hz, 	34ax5ax 	= 9.9Hz, 	3j 4axseq = 	4.9Hz, 
45ax2ax = 0.8Hz, 	H4AX), 	1.77(1H, 	dddd, 	22eq2ax = 13.4Hz, 
32eqiax = 	2.7Hz, 	42eq4eq 	= 1.9Hz, 	5J2eqseq = 	0.3Hz, 
H2EQ), 	3.41(3H, S, 	ONe), 	3.76(1H, 	ddd, 	235ax5eq = 11.7Hz, 
33sax4ax = 	9.9Hz, 	35ax4eq 	= 3.2Hz, 	H5AX), 3.84(1H, 
ddddd, 	2seq5ax 	= 11.7Hz, 35eq4ax 	= 4.9Hz, 	3 5eq4eq 	= 
4.0Hz, 	4seqiax = 0.4Hz, 	55eq2eq = 0.3Hz, 	H5EQ), 4.61(1H, 
ddd, 	3iax2ax -- 7.8Hz, 	3iax2eq = 2.7Hz, 	4tax5eq = 0.4Hz, 
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H1Ax), 6c(CDC13,  50 MHz), 30.6(Me), 38.4(C4), 43.8(C2), 
55.9(C5), 60.6(OMe), 69.0(C3), 99.8(d); FABMS in/z 
147.10212 (MH+ C7H1503 requires 147.10211); FABMS m/z 
146(M) 130, 116, 99, 72, 46. 
2 • 4DIHYDROXY-4-METHYLTETRAHYDROPYRAN (63): 
The acetal (146 mg, 1 mmol) was dissolved in dry THF 
(2 ml) along with AG50 WX2 ion exchange resin (1 g) and 
water (180 Al, 1 mmol). The mixture was then stirred at 
50°C for 1 hour. 	After cooling, the mixture was 
evaporated onto silica and purified by flash column 
chromatography to give a mixture of diastereomers as a 
clear colourless oil (119 mg, 91%). 	The product was 
t,1.c. and NNR identical to a standard sample. 
n-BUTYL ACETATE (101):-
Sodium acetate (100) (1.5 g, 18 mmol) was mixed with 
tri-n-butylphosphate (6 ml) and refluxed for 6 hours until 
the solution was homogeneous. The mixture was then cooled 
to room temperature and distilled through the condenser 
and an ice cooled trap into a liquid nitrogen cooled trap 
at oil pump pressure. This gave a clear liquid which 
smelt strongly of pear drops (1.85 g, 89%), b.p. 124-126°C 
(lit. 124-126°C); 6H  09(3H, in, CH a ), 1.5(4H, in, 2xCH 2 ) 1  
2.05(3H, S, Me), 4.05(2H, t, J=7Hz, CH 2); 'max(thin film) 
1725 cm' (C=O). 
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2-' 3C-n-BUTYL- (3-HYDROXY-3-METHYL-5, 5-DIMETHOXY) 
PENTANOATE (102): 
Butyl lithium (7.5 ml of a 1.6M soin,, 12 mmol) was 
added to a stirred solution of diisopropylamine (1.67 ml, 
1.21 g, 12 mmol) and THF (40 ml) at -78°C under nitrogen 
over 10 minutes. 	The mixture was then warmed to 0°C 
before being recooled to -78°C for the addition of 
n-butylacetate (101) (1.38 g, 12 mmol). The mixture was 
left for a further hour at -78°C before the addition of 
the ketone (97) (1.77 ml, 1.76 g, 12 mmol) and finally 
left at -78°C and room temperature for I hour each. The 
mixture was then diluted with saturated ammonium chloride 
(25 ml) and the tetrahydrofuran evaporated. The residue 
was extracted with ether and the extract was washed with 
saturated sodium chloride and dried over magnesium 
chloride before being filtered and evaporated to give an 
essentially pure (tic) clear colourless oil (3.0 g, 100%); 
6H(CDC13, 60 MHz), 0.9(3H, m, CH3), 1.1(3H, d, 3JCH=6HZ, 
CH 01  1.5(4H, in, 2xCH 2), 1.7(2H, dd, 3JCH=6HZ, 3JHH=9H2, 
CH 2), 2.,4(2H, dm, 'JCH=128HZ, CH 2), 3.25(6H, s, 2xOCH3 ) 1  
3.6(lH, bs, CH), 4.1(2H, t, 3JHH=9HZ, CH 2), 4.6(lH, t, 
3J=9Hz, CH). 
4_1 3C-1, 1-DIMETHOXY-3 . 5-DIHYDROXY-3-METHYLBUTANE (75):7 
The ester (102) (3.0 g, 12 mmol) was dissolved in THF 
(10 ml) and added to a stirred suspension of lithium 
aluminium hydride (912 mg, 24 mmol) and THF (80 ml) under 
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nitrogen. The mixture was •refluxed for 1 hour, cooled, 
and diluted with water (1.8 ml), 10% sodium hydroxide (2.7 
ml) and water (1.8 ml) in succession and stirred for 15 
minutes. 	The mixture was diluted with ether (200 ml), 
filtered, dried over magnesium sulphate, filtered and 
evaporated to give an essentially pure oil which was tic 
homogeneous with a standard sample (1.84 g, 86%); 
6H(CDC1 3, 60 MHz), 1.1(3H, d, 3CH  =6Hz, CH.), 1.6(2H, dt, 
'JCH128HZ, 3JHH9HZ, CH2), 1.7(2H, dd, 3JCH=6HZ, 3 HH 
9Hz, CH 2), 3.25(6H, s, 2xOCH3), 3.6(2H, s, 2xOH), 3.7(2H, 
dt, 3JHH=9HZ, 3JCH6HZ, CH 2), 4.6(1H, t, 3JHH=9HZ,  CH). 
2 -METHOXY-4-HYDROXY-4-METHYLTETPAHYDROPYRAN (99) : - 
Mevalonic lactone (61) (520 lug, 4 mmol) in dry 
methylene chloride (40 ml) at -78°C was treated with 
diisobutylaluminium hydride (4.4 nil of a lM soln., 
4.4 nuuol) and allowed to warm up to 5°C. The mixture was 
recooled to -78°C and treated with excess methanol before 
being warmed up to room temperature and evaporated to a 
gum. The gum was covered with methanol and dissolved on 
the addition of 2N hydrochloric acid to give a clear 
solution. 	The mixture was finally neutralised with 5N 
sodium hydroxide and extracted with chloroform to give 
after silica flash column chromatography two clear 
colourless diastereomeric oils (92 mg, 16%) and (192 mg, 
33%) which were tic, NNR and b.p. homogeneous with 
compounds prepared by another route. 
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3TRIMETHYLSILYLPROP-2-YN-1-OL (111): - 
Prop-2-yn-i-ol (110) (7 g, 7.27 ml, 0.125 mol) in THF 
(40 ml) was added to ethylmagnesiumbromide (freshly 
prepared from magnesium (6.1 g, 0.25 mol) and ethyibromide 
(28 g, 19.18 ml, 0.25 mol)) and stirred at 0°C for 1.5 
hours. Trimethylsilyichioride (28 g, 32.7 ml, 0.25 mol) 
was added over 1 hour and the mixture was kept at 50°C for 
1 hour and left at RT overnight. 	Saturated ammonium 
chloride was added (200 ml) and the mixture was extracted 
with ether (3 x 100 ml).. The extract was washed with 
brine (100 ml) and concentrated before being stirred with 
ice (7.5 g), ethanol (25 ml) and conc. HC1 (2-3 drops) for 
1 hour. The mixture was then extracted with ether, the 
extract was dried with magnesium sulphate, filtered, 
concentrated and distilled to give a clear colourless oil 
(5,47 g, 34%); b.p. 79-'82°C, 10 mm Hg (lit78. 76°C 11 mm 
Hg);. 6H(CDC13,  60 MHz), 0.0(9H, 5, 3xCH3), 2.2(H, bs, OH), 
4.2(2H, 5, CH 2); ElMS mu/z 113(M-15), 85, 75, 73, 61, 45. 
3-BROMO--1-TRIMETHYLSILYLPROP-1-YNE (112):- 
The alcohol (111) (12.8 g, 0.1 mmoi) in DMF (80 ml) 
was added to a solution of DMF (400 ml), triphenyl 
phosphine (100 g, 0.37 mol) and bromine (14 ml, 0.27 mol) 
and stirred under nitrogen at 0°C for 3 hours and room 
temperature overnight. 	The mixture was extracted with 
petrol (40-60) (3 x 500 ml) and the extract was washed 
with saturated sodium bicarbonate (330 ml), dried over 
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magnesium sulphate, filtered, evaporated and distilled 
after passage through a short silica column to give a 
clear colourless oil (10.6 g, 55%), b.p. 39-42°C 1 nun Hg 
(lit;' 8. 44-45°C, 2mm Hg); 6H(CDC13,  60 MHz), 0.0(9H, s, 
3xMe), 3.7(2H, s, CH 2); vmax(thin film) 2180 cm' (CC); 




The  bromide (112) (1.9 g, 10 mmol) was stirred 
overnight with activated zinc (1.95 g, 30 mmol) in dry THF 
(20 ml) at RT. The ketone (74) (1.72 g, 10 mmol) was then 
added and the mixture ref luxed for four hours. The zinc 
was filtered off and the yellow gum remaining after 
evaporation of the THF was purified by flash column 
chromatography on silica gel to give a clear colourless 
oil (1.80 g, 63%), b.p, 93-95°C 1mm Hg; 6H(CDC131 80 MHz), 
0.1(9H, S, Me3Si), 1.3(3H, s, Me), 1.6(6H, bin, 3xCH 2 ) 1  
1.9(2H, dd, J=5.7Hz, 1.4Hz, CH 2) 2.4(2H, d, J=1.7Hz, CH 2), 
3,2(lH, bs, OH), 3.5-4.0(4H, in, 2xCH 2), 4.6(1H, bs, CH); 
ElMS m/z 284(M), 266, 200, 182, 173; Pmax(thin film) 2180 
cm-1(m) (-CC-), 3500 ciu' (bs)(OH); FABMS m/z 285.18860 
(NH C15H2903S1 requires 285.18858). 
1-TRIMETHYLSILYL-4. 6-DIHYDROXY-4-METHYLHEX-1-YNE (109):-
The alkyne (113) (1.1 g, 3.7 mmol) was stirred at 40°C 
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for 1 hour in ethanol (920 nil) along with 2N hydrochloric 
acid (1.2 ml). The mixture was neutralised with sodium 
hydroxide (5N) (phenolphthalein indicator) and dried over 
magnesium sulphate before being filtered, evaporated and 
purified by flash column chromatography on silica gel to 
give a clear colourless oil (709 mg, 96%), b.p. 55-57°C, 
0.5 mm Hg; 6H(CDC13,  80 MHz), 0.1(9H, s, Me3Si), 1.3(3H, 
S, Me), 1.8(2H, t, 3J=5Hz, CH 2), 2.4(2H, s, CH 2), 2.9(2H, 
bs, 2xOH), 3.9(2H, t, J=5Hz, CH 2); vmax(thin film) 2180 
cm 1 (CC) 3400 cm-1 (OH); FABMS m/z 201.131071 (NH 
C10H 202S1 requires 201.13107); FABMS m/z 201, 183. 
REACTION OF OSMIUM TETROXIDE WITH 1-TRIMETHYLSILYL-4,6-
DIHYDROXY-4-METHYL HEX-1-YNE (109) :- 
Tertiary butyl hydroperoxide (2 ml of 3M soln. in 
toluene, 6 mmol) was added at 0°C under nitrogen to a 
solution of the alkyne (109) (240 mg, 1.2 nunol) in 
methanol (10 nil) followed by osmium tetroxide (17 mg, 
0.06 nunol) and stirred for 2 hours. 	After stirring at 
room temperature overnight, the solution was diluted with 
saturated sodium metabisuiphite (2 ml) and, the bulk 
solvents were removed in vacuo. 	Saturated ammonium 
chloride was added and the mixture extracted with 
methylene chloride (3 x 5inl). The extract was dried over 
magnesium sulphate, filtered, evaporated and purified by 
flash column chromatography on silica gel to give a clear 
colourless oil (50 mg, 21%). The product was t.1.c., NMR 
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and b.p. homogeneous with a standard sample of the 
starting material. 
OZONOLYSIS OF 1-TRIMETHYLSILYL-'4 , 6-DIHYDROXY-4-METHYL 
HEX-1-YNE (109) :- 
The alkyne (109) (900 mg, 4.5 inmol) was dissolved in 
methanol (20 ml) and ozonised at -78°C for forty minutes. 
The mixture was then allowed to warm up to room 
temperature over 30 minutes before being evaporated and 
purified by flash column chromatography on silica gel to 
give a clear colourless oil (290 mg); RF = 0.2-0.3 (50/50 
ethyl acetate/hexane); FABMS m/z 173, 155, 131, 113; 
IR(thin film) 1770-1700 cm-1 (C=O), 3400 cm' OH; 
oc(CDC13, 50 MHz) 26.5, 41.7, 45.0, 51.4, 58.7, 71.5, 
95.0, 172.5 (C=O); 6H(CDC13,  200 MHz), 1.26(s, CH 01 
1.32(s, CH3), 1.75(m, CH 2), 2.5(q, Jl5.3Hz, CH 2), 3.66(s, 
OCH3), 3.7(in, CH 2), 4.3, 4..6(in, CH 2). 
METHYL TRIPHENYLPHOSPHONIUM IODIDE: - 
Triphenyiphosphine (27.5 g, 0.11 mol) was dissolved in 
dry benzene (22.5 ml) and placed in a pressure bottle 
which was cooled in an ice salt bath before addition of 
iodoinethane (9.35 nil, 21.3 g, 0.15 mci). The bottle was 
then left to stand sealed at RT for 1 day. The white 
precipitate was filtered off and washed with hot benzene 
before being dried at 100°C overnight in a vacuum pistol 
(41 g, 100%), in.p. l82184°C (lit8 l. 183-184°C). 
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1(TETRAHYDROPYRANYL-2-OXY) -3-METHYLBUT-3-ENE (123): 
Dry ether (250 ml) and triphenylmethylphosphonium 
iodide (17.85 g, 44 inmol) were stirred at room temperature 
under argon while butyl lithium (32 ml of 1.6M, 51 imuol) 
was added over 10 minutes. The solution was left for 4 
hours at room temperature before the ketone (74) (8.6 g, 
50 mmol) was added and the solution stirred overnight. 
The mixture was then ref luxed for 5 hours, allowed to cool 
and filtered. 	The filtrate and ether washings of the 
filter cake were washed with water until neutral then 
dried over calcium chloride, filtered, evaporated and 
purified by flash column chromatography on silica gel to 
give a clear colourless oil (1.3 g, 15%); b.p. 58-60°C 8 
nun Hg; 6H(CDC13,  60 MHz), 1.6(6H, bm, 3xCH 2 ) 1  1.8(3H, s, 
CH3), 2.3(2H, t, 3J=7Hz, CH 2), 3.3-4.1(4H, bin, 2xCH 2 ) 1  
4.6(H, bs, CH), 4.8(2H, bs, CH 2); FABMS in/z 171.13849 (MH+ 
C10H. 902 requires 171.13850), ElMS m/z 169, 129, 101, 85, 
69, 41. 
1- (TETRAHYDROPYRANYL-2-Oxy) -3-METHYLBUT-3-ENE (123):-
The alcohol (122) (10.1 ml, 0.1 mol),. dihydropyran 
(81) (13.7 ml, 0.15 mol) and p-toluenesulfonic acid (50 
mg, 0.2 inmol) were stirred at room temperature for 20 
minutes in dry methylene chloride (200 ml). The mixture 
was then diluted with ether (200 ml), washed with brine 
(100 ml), dried over sodium sulphate, and evaporated to 
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give an essentially pure oil (17 g, 100%) which was 
t.l,c., NMR and b.p. identical to a standard sample. 
1- (TETRAHYDROPYRANYL-2-OXY-) 3-METHYLBUT-3-ENE EPDXIDE 
(124) :- 
The alkene (123) (3.4 g, 20 imnol) in methylene 
chloride (50 ml) was refluxed with m-chloroperbenzoic acid 
(4.3 g, 20 mmol) for 3 hours and left stirring overnight 
at room temperature. The precipitate was filtered off and 
the filtrate was washed with 20% sodium sulphite (5 ml), 
10% sodium bicarbonate (3 x 5 ml) and brine (5 ml) before 
being dried over magnesium sulphate filtered and 
evaporated to give an essentially pure clear colourless 
oil (3.7 g, 100%), b.p. 65-67°C 1 mm Hg; 6H(CDC13, 200 
MHz), 134(3H, s; CH 01  1.5-2.0(8H, m, 4xCH 2), 2.6(2H, 
dddd, 2JHH=142HZ, J=2.5, H, 0.6), 3.5(2H, in, CH Of 
3.85(2H, m, CH 2), 4.57(1H, 5, CH); FABMS mhz 187.13340 
(C10H1903 requires 187.13341); 187(MH)+ 185(M_H)+. 
1 .2-DIHYDROXY-2-METHYL-4- (TETRAHYDROPYRANYL-2-OXY) -BUTANE 
(125):- 
The epoxide (124) (380 mg, 2 nimol) was refluxed for 3 
days in water/THF (50:50) (10 ml) along with sodium 
hydroxide (5N, 2 nil). 	The mixture was neutralised and 
evaporated onto silica to give, after flash column 
chromatography, a clear colourless oil (95 mg, 23%), b.p. 
79-81°C; 1 mm Hg; 6H(CDC13,  60 MHz); 1.2(3H, 5, CH 3) 
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1.7(8H, bin, 4xCH 2), 3.4(2H, 5, CH), 3.3-4.1(6H, bin, 
2xCH 2, 20H), 4.6(H, bm, CH); FAB MS m/z 205(MH) 101, 85.. 
OXIDATION OF 1. 2-DIHYDROXY-'2-METHYL-4 (TETRAHYDROPYRANYL-
2-OXY)BUTANE (125):- 
The diol (125) (300 mg, 1.5 mmol) in dry methylene 
chloride (10 ml) was stirred along with sodium acetate (20 
mg) and pyridiniuin chlorochromate (485 mg, 2.25 mmol) at 
room temperature for 4 hours., The solution was diluted 
with ether and filtered through a silica plug to give, 
after flash column chromatography on silica gel, a clear 
colourless oil (200 mg, 77%). The product was t.l.c., NMR 





lithium (12.5 ml of a 1.6M soln.,, 20 mmol) was 
added to a stirred solution of THF (75 ml) and 
diisopropylamine (2.8 ml, 20 mmol) at -78°C under nitrogen 
and the mixture was allowed to warm up to 0°C over i.hour. 
The mixture was recooled to -78°C and ethyl acetate (1.95 
ml, 20 mmol) was added. After I hour at -78°C the ketone 
(83) (1.06 ml, 20 mmol) was added and stirred for i hour 
at -78°C and I hour at room temperature. The mixture was 
diluted with ammonium chloride (50 ml) and the THF 
evaporated in vacuo. The residue was then extracted with 
ether and the extract washed with brine, dried over 
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magnesium sulphate, filtered, evaporated and purified by 
flash column chromatography to give a clear colourless oil 
(3.2 g, 100%); b.p. 64-66°C, 11 mm Hg; 6H(CDC13,  60 MHz), 
1.4(3H, S, CH0 1  1.35(3H, t, 3JHH=7HZ, CH3), 2.7(2H, s, 
CH 2), 3.9(1H, bs, OH), 4.2(2H, q, 3JHH=7HZ, CH 2), 
5.06.3(3H, m, CH 2CH); vmax(thifl film) 1740 cm' (C=O), 
3500 cm' (OH); FAB MS m/z 159.10210 (MH C8H1503 requires 
159.10211); 159, 141. 
3.5DIHYDROXY-3-METHYLPENT-lENE (129e):-
The ester (128e) (3.2 g, 20 lumol) in THF (10 ml) was 
added to a solution of THF (100 ml) and lithium aluminium 
hydride (1.52 g, 40 unuol) and refluxed for 1 hour. Water 
(2.6 mol), 10% sodium hydroxide (4 ml) and water (7.8 ml) 
were added successively and the mixture stirred for a 
further 15 minutes. The mixture was diluted with ether, 
filtered, dried over magnesium sulphate, filtered and 
evaporated and purified by flash column chromatography on 
silica gel to give a clear colourless oil (2.1 g, 90%); 
b.p. 4l43°C 0.5 mm Hg; SH(CDC13,  60 MHz), 1.4(3H, s, 
CH 01  ]..8(2H, m, CH 2), 3.4(2H, bs, 2xOH), 3.8(2H, t, 
3JHH=6HZ, Cl!2), 5.0-6..3(3H, m, CH 2CH); FABMS m/z 117.09154 
(MH+ C 6H1302 requires 117.09155); FABMS m/z 117, 99, 81. 
2, 4-DIMETHYL--4-ETHENYL-1, 3-DIOXAN (130eii) : - 
The alcohol (129e) (9.1 g, 78 mrnol) was stirred in dry 
methylene chloride (40 ml) with acetaldehyde (40 ml), 
120 
anhydrous copper sulphate (5 g, 2 eq) and p-toluene 
sulfonic acid (200 lug) for 2 hours at room temperature. 
The mixture was diluted with ether (100 ml), washed with 
saturated sodium bicarbonate, dried with magnesium 
sulphate, filtered and evaporated to give a clear 
colourless oil after flash column chromatography on 
silica. The product was characterised as a mixture of two 
diastereoiners (10 g, 91%); boiling range 95-115°C; 
ÔH(CDC1 3, 200 MHz), 1.20-1.37(12H, m, 4xCH 3), 1.5-2.0(4H, 
m, 2xCH 2),, 36-3.9(4H, in, 2xCH 2), 4.8-5.9(6H, m, 2xCH 2 CH); 
oc(cDC]. 3, 50 MHz), 19.8, 21.1, 21.3, 30.7(4xCH 3), 33.51, 
33.9(2xC3), 62.5, 63.2(2xC4), 72.9, 74.4(2xC2), 92.1, 
93.6(2xCl), 111.4, 115.3(2xC8 2 ) 1 141.7; 145.0(2xC7 2). 
FABMS m/z 143.10719 (M& C8H1502 requires 143.10720); 
FABMS m/z 143, 141. 
2 ,4-DIMETHYL-4-ALDEHYDO-1, 3-DIOXAN (13 lii) : - 
The alkene (994 mg, 7 mmol) in dry methylene chloride 
(30 ml) was subjected to ozonolysis for 15 minutes at 
-78°C until the solution became blue. Triphenylphosphine 
was then added and the mixture allowed to warm up to room 
temperature over 1 hour. The mixture was concentrated in 
vacuo and the residue purified by flash column 
chromatography on silica gel to give a clear colourless 
oil (910 mg, 90%). The product was characterised as a 
mixture of diastereomers. 	6H(CDC1 3 1 200 MHz), 
1.1-1.4(12H, in, 4xCH0 1  1.5-2.0(4H, m, 2xCH 2), 3.54(lH, 
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td, 2J6ax6eq= 3J6ax5ax=11.8Hz, 3J6axseq2.8HZ, MAX), 
3.85(1H, td, 2J6ax6eq 2J6ax5ax11.7Hz, 3 6ax5eq=27 ' 
MAX), 4.08(1H, ddd, 2J6eq6ax=11.7HZ, 3 6eqax=6.2Hz, 
3 6eq5eq=2.oHz, H6Eq), 3.9(1H, m, H6EQ), 4.68(1H, q, 
q5(qo, s) 
J=5Hz, CH), 4.95(1H, q, 3J=5Hz, CH); oc(CDC13, 50 MHz) 
16.2, 20.7, 21.1, 23.0(4xCH3), 28.1, 30.1(C3x2), 61.9, 
63.9(C4x2), 	793(C2), 	92.5, 	96.7(C1x2), 	202.1, 
204.3(2xC=O); Pmax(thin film) 1740 ciu' (C=O); FABMS m/z 
145.08647 (MH C?H1303 requires 145.08646); FABMS in/z 145, 
143, 115. 
CYCLOHEXANESPIRO2'(1' ,3'-DIOXOLAN)--4'-ONE (134):- 
To a solution of cyclohexanone (132) (65.2 g, 
0.67 mol) and p-toluenesulfonic acid hydrate (0.15 g, 0.8 
nimol) in toluene (300 ml) at reflux was added, dropwise 
over 4 hours, a solution of glycolic acid (133) (40.8 g, 
0.54 niol) in water (20 ml). The mixture was heated for a 
further 5 hours (the water produced in the reaction was 
removed via a Dean and Stark apparatus), cooled to room 
temperature, treated with anhydrous sodium acetate (0.25 
g, 3 inmol), and stirred for 1 hour. 	The mixture was 
filtered, and the filtrate was evaporated under reduced 
pressure to afford a yellow oil which was distilled to 
yield the dioxolan one as a colourless liquid (50.4 g, 
60%), b.p. 76°C 1 mm Hg (lit80. 70°C, 0.5 mm Hg), 6H(CDC1 3
1 
60 MHz), 1.4-1.9(10H, in, (CH2)x5), 4.3(2H, s, CH 2), 
vmax(thin film) 1795 cnr' (C=O). 
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5' -OXACYCLOHEXANESPIRO-2' (1' 3 '-DIOXOLAN) -4 '-YLTRIPHENYL 
PHOSPHONIUM BROMIDE (136):- 
A mixture of N-broinosuccinimide (62.3 g, 0.35 mol), 
dioxolanone (134) (50.4 g, 0.32 iuol) and azobisiso-
butyronitrile (200 mg, 1.2 mmol) in carbon tetrachloride 
(500 ml) was heated to ref lux and irradiated by a 500W 
tungsten lamp. After vigorous reaction, the solution was 
left to reflux for one hour then the pale yellow 
suspension was cooled to 5°C and the white precipitate of 
N-succiniinide filtered .off and washed with carbon 
tetrachloride (2 x 50 ml). 	The combined filtrate and 
washings were concentrated in vacuo to afford 
5'-bromocyclohexanespiro-2'-(1'3 '-dixolan) -4'-one 	as 	a 
yellow lachryniatory oil (Pmax(thifl film)1810 cm-1). The 
oil was stirred at 20°C in toluene (500 ml) whilst a 
solution of triphenyiphosphine (49 g, 0.19 mol) in toluene 
(250 ml) was added dropwise over 1 hour. The solution was 
stirred overnight at room temperature then the white 
precipitate was filtered off and washed with toluene and 
ether. The crude product was purified by dissolution in 
ethanol then reprecipitation with ether to obtain the 
required phosphonium salt as a white solid (66.7 g, 42%), 
M.P. 187-189°C (1it 80 . 1890C); 6H(CDC13 , 60 MHz), 
l.1-1.7(8H, broad, cyclohexyl), 1.8-1.9(2H, bm, CH 2 ), 
7.58.0(16H, b, PPh3 ), P a (nUjOl mull) 1795 cm' (C=O); 
FABMS m/z 497.08815 (M C 26H 2603 PBr requires 497.08817). 
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4,6- (ETHYLIDENE)-4-METHYLBUTYLIDENECYCLOHEXANESPIRO-2' - 
(1'.3'-DIOXOLAN)-4'-ONE (137):- 
To the phosphorane generated from the phosphonium salt 
(136) (9.92 g, 20 mmol) and DABCO (2.7 g, 12 eq) in dry 
benzene (100 ml) under nitrogen at 80°C was added the 
aldehyde (131ii) (2.88 g, 20 mmol) in benzene (20 ml) in 
5 ml portions. The mixture was stirred at 100°C for l 
hours -after which time it was cooled and a white 
precipitate filtered off. The filtrate was concentrated 
in vacuo and the residue applied to a silica dry flash 
column to give a mixture of diastereomeric pairs of 
geometrical isomers (3.9 g, 69%). 	The alkene (137) 
(1.9 g, 6.7 mmol) in hexane (125 ml) was then irradiated 
at reflux under a 400W tungsten lamp with iodine (139 mg, 
1.09 mmol) for 3 hours. 	The solution was cooled and 
washed with sodium thiosuiphate, and brine before being. 
dried over magnesium sulphate, filtered, evaporated and 
purified by flash column chromatography to yield two 
almost pure white solid diastereomers (120 mg, 6.3%); 
6H(CDC13, 200 MHz), I.25-1,32(6H, in, 2xMe), 1.42-2.00(12H, 
M, 6xCH 2), 3.6(H, _td, 3Jaxeq3.OHZ 3Jaxax 2Jaxeq8.6HZ, 
6ax), 3.9(H, m, 6eq), 4.75(H, q, 3J=5.lHz -O(CH3)Cfl-O-), 
5.6(H, s, -CH=); ôc(CDC131 50.3 MHz), 21.1(C-8 or C-9), 
22.6(C-311, C-511), 23.9(C-4") , 28.3(C-8 or C-9), 34.5(C-5), 
35.9(C-211, C-611), 63.9(C-6), 73.8(C-4), 94.5(C-7), 112.1 
(C-21), 112.4(C-3), 137.3(C-51), 162.6(C-41); P(flujOl) 
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1790 cm-1 C=O; FABMS m/z 283.15444 (MH+ C1 H230,requires 
283.15454) and (150 mg, 7.9%); 6H(CDC13, 200 MHz), 
1.1-1.3(6H, in, 2xMe), 1.3-1.9(12H, in, 6xCH 2), 3.65(H, in, 
6ax), 3.9(H, in, 6eq), 4.88(H, q, 3J=5.lHz), 5.76(H, s, 
-CH=); oc(cDc13,  50.3 MHz), 21.3(C-8 or C'-9), 22.8(C-311 , 
C-511), 24.2(C-411), 28.8(C-8 or C-9) , 35.2(C-5), 35.9(C-2", 
C-'611), 	63.1(C6), 	74.2(C-4), 	94.1(C-7), 	113.3(C-21), 
119.7(C-3), 137.9(C'-51), 160.7(C-41); max(nuj01) 1790 
cnr' (C=O); FABMS m/z 283.15455 (MW C15H 2305 requires 
283.15454). 
CULTURE OR MICROORGANISMS 
Rhodopseudomonas capsulata was grown anaerobically 
with stirring between 2530°C under light on the following 
medium S: Glutamate, 3.8 g; DL-maiate, 2.7 g; sodium 
hydroxide, 1.6 g; potassium dihydrogen phosphate, 0,5 g; 
dipotassiuin hydrogen phosphate, 0.5 g; diammoniumhydrogen-
phosphate, 0.85 g; glass distilled water to 1 litre; then 
magnesium sulphate heptahydrate, 1 ml from stock of 200 
g/l; nicotonic acid, 0.1 ml from stock of 10 mg/ml; 
thiamine hydrochloride, 0.1 ml from stock of 10 mg/ml; 
biotin, 0.1 ml from stock of 100 Ag/ml; manganese chloride 
tetrahydrate, 0.1 ml from stock of 10 mg/ml; ferric 
citrate, 0.5 ml from stock of 5 mg/ml; then adjusted to pH 
.9; 0.2% yeast extract. 
The medium was autoclaved at 121°C for 25 minutes 
before use, 2% agar was added for slopes. 	The. 
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microorganism was cultured as follows: a single slope of 
Rh. capsulata was used to seed a start culture (100 ml, 
Medium S) which was grown as above for 2 days. This was 
used as a 10% inoculumn for production cultures.  
MEASUREMENT OF CULTURE GROWTH AND METABOLITE PRODUCTION 
HPLC Method 
Eight shake flasks (250 ml) of medium S were each 
inoculated with a 10% inoculum of freshly grown stationary 
phase Rhodopseudomonas capsulata culture. 	At initial 
intervals of 12 hours and latterly 24.hours, one flask was 
removed and the cells harvested, lysed, and extracted (see 
isolation procedure). 	The weight of residue after 
extraction was taken as a measure of cell mass and the 
extract was analysed for ubiquinone-10 (51) using reverse 
phase high pressure liquid chromatography. 	100 x 1 mm 
column, Hypersil-ODS 5 m; solvent, 10% ethyl acetate/l% 
acetic acid/methanol; detection at 280 nm. 
Turbidity Method 
1 ml Samples of mediums (300 ml) inoculated (10%) with 
Rh. capsulata were monitored for adsorption at 625 nm on 
an ultra violet spectrometer (see General Methods). The 
increase in absorption due to the increase in turbidity of 
the medium was taken as a measure of cell growth. 
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ISOLATION OF UBIQUINONE-10 (51) 
The bacterial cells were harvested by centrifugation 
(15,000 g for 20 mm) and washed free of medium with 
water. 	The material was suspended in ethanol (300 
ml/litre of medium) and dried in vacuo. The dry powder 
was then extracted four times with hot acetone (100 ml/ 
litre of medium) or until the extract was colourless. The 
combined acetone extract was evaporated to dryness and 
purified by preparative thin layer chromatography on 
silica. A red band (Rf=06) isolated after elution with 
hexane/ether 70/30 was repurified on silica using 
chloroform/hexane 50/50 as eluent to give ubiquinone-10 
(51) (23 mg/litre of medium) which was t.l.c. homogeneous 
with a standard sample. FABMS m/z 864(MH+), 863(M+), 680, 
683, 684, 666, 667, 408, 196, 182, 180. 	6cC360 MHz, 
CDC1 3) 11.8(ArMe), 15.9(C-3',7',ll',15',l9',23',27',31', 
351), 17.6(C391), 25.2(C-1), 25.5(C-40), 26.6(C-5,9,13, 
17,21,25,29,33,37), 	39.6(C-4,8,12,16,20,24,28,32,36), 
61.0(OMe), 118.8(C-2), 124.2(C-6,10,14,18,22,26,30,34,38), 
134.8(C-3, 7,11,15,19,23,27,31,35,39). 
FEEDING STUDY PROCEDURE 
Typically 3 shake flasks (250 ml) of medium S were 
inoculated with a 10% inoculum of freshly grown stationary 
phase I  Rhodopseudomonas 	capsulata 	and 	inoculated 
anaerobically under light at 25-30°C with stirring for 38 
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hours. 	The flasks were then inoculated with a stable 
isotope tracer (1 ininol per flask) and incubated for 
another 46 hours (84 hours in total). The ubiquinone-lo 
(51) was then isolated and analysed using 13C NNR 
spectroscopy. 
ASSAY METHODS 
HMGC0A SYNTHASE ASSAY 
In the standard assay a 1 cm silica cuvette contained 
(at 300C), 40 inN tris-HC1, pH 8.2, 20 mM magnesium 
chloride, 16 AM acetoacetyFCoA and enzyme (10-100Al) in 
a total volume of 0.995 ml. The enzyme was added last and 
the rate of acetoacetyl hydrolysis measured (if any). 
Then acetyl C0A was added (5 Al of 8.6 mM soln.) and the 
increase in the rate of acetoacetyl-00A disappearance at 
303 nm measured to give the HNGC0A synthase activity. The 
apparent extinction coefficient (E) of acetoacetyl C0A 
under these conditions is 20 x 103. litre mo1 1 at 303 
nm'. 
The observed rate was converted to the specific. 
activity and compared with the specific activity obtained 
by Middleton and Tubbs25. A unit of enzymatic activity is 
defined 23 as the amount of enzyme necessary to convert 1 
iuol of acetoacetyl C0A into product per minute under the 
conditions described by Middleton and Tubbs. The change 
in absorption that would be observed if 1 tmol of 
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acetoacetyl C0A was converted into product in a 2 ml 
cuvette where cell path length is 1 cm is given by the 
Beer Lambert Law:- 
1 x lO 
dA = 20 x 103 x 	 x 1 = 10 
2 x 1O 
c 	. 	1 
Thus the rate in units for the yeast HNGC0A synthetic 
assay (pg. 82) is:- 
Rate = 0.293/10 = 0.0293 units 
However, the specific activity is measured in units/mg 
of protein. Thus the amount of protein in 20 Al of enzyme 
solution causing this rate is given by 
20 x 106 x 14.75 x 10 	= 0.2950 mg 
where the second term is the protein concentration 
obtained from the Bradford assay. The specific activity 
determined was:- 
0.0293/0.2950 = 0.0994 units mg1 
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Succinate Dehydrocienase Assay' 02 
The test cuvette (1 cm silica) contained 10 Al of 5 mM 
DCPIP, 100 Al of 10 inN potassium cyanide, 50 Al of PMS (3 
mg/ml freshly prepared), 4 Al of 1M succinate and 
typically 20 Al of membrane suspension. All the reagents 
were made up in phosphate buffer (50 inN, pH 7.7) which was 
added to give a final volume of 1 ml. All reagents except 
PMS were present in the blank cuvette. 	Succinate 
initiated the reaction. The absorption was measured at 
600 nm and 15°C. 
Preparation of Cell Free Extracts 
1, Fresh bakers yeast (100 g) was autolysed at 38°C for 
12 hours with toluene (11 ml). The mixture was then 
diluted with cold deionised water (90 ml) and 
centrifuged at 15000 g for 20 minutes. 
The supernatant (150 ml) was diluted with 
commercial ethanol (50 ml) and stirred at RT for 2 
hours. The mixture was then centrifuged at 2000 g for 
20 minutes at 18°C and the consequent supernatant left 
at -3°C for forty minutes. 	The precipitate was 
collected by centrifugation at 2000 g for 20 minutes 
and dissolved in 10 inN potassium phosphate buffer pH 
7.8 containing 1 inN DTT to give a final volume of 
10 ml. An assay was performed on this final solution. 
2. Fresh bakers yeast was stirred to a paste with water 
and centrifuged to collect the cells (5,000 g for 15 
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mm.). 	The cells were resuspended to 0.5 g/ml wet 
weight with tris-sulphate buffer (0.1 M pH 9.4/10 mM 
DTT) and incubated with shaking for 5 min at 30°C. 
The cells were collected by centrifugation (5,000 g 
for 5 mins), washed with phosphate buffer (20 mM pH 
7.4/1.2M sorbitol), collected by centrifugation as 
above and resuspended in the phosphate buffer to which 
0.15 g/ml Zymolase was added (5 mg/g wet weight). The 
cells were incubated with shaking at 30°C until 
sphaeroplast formation was 80% complete (- 1 hr). The 
sphaeroplasts were collected by centrifugation 
(2,500 g for 10 mm)' and washed with phosphate buffer 
before being hand homogenised in phosphate buffer 
(20 mM pH 7.4/0.6M mannitol). 	The cell debris was 
spun out (12,500 g for 15 mm) and the supernatant 
assayed for HNGCOA synthase activity. 
3. Rhodopseudomonas capsulata was grown anaerobically 
from a 10% inoculum on medium S (1 litre). The cells 
were grown for 36 hours at 25-30°C under illumination 
from 2 banks of 6 x 60W Osram lamps. 
The cells were harvested by centrifugation 
(20,000 g for 15 minutes), washed with phosphate. 
buffer (50 inN pH 7.0), and disrupted in a French 
pressure cell after resuspension in phosphate buffer 
at 16,000 p.s.i. Residual intact cells and the larger 
debris were removed from the extracts by low speed 
centrifugation at 4°C (20,000 g for 15 minutes) and 
13]. 
pigmented particles were then collected by ultra 
centrifugation (150,000 g for 90 minutes) of the 
supernatant. 	The particles were resuspended in 
phosphate buffer (50 mM pH 7.0) and recentrifuged 
under the same conditions. Assays were performed on 
the cell extract after French press, the cytoplasmic 
fraction and the cell debris after French press, the 
ultracentrifuged pellet and supernatant and the washed 
ultracentrifuged pellet and supernatant. 
Protein Determination 
The Bradford microassay procedure was used for all the 
steps of the purification. 
Several dilutions of protein standard BSA were 
prepared 0 -, 20/Al/ml in 4 jAl steps and 0 - 100 ml in 
10 Al steps. 
0,8 ml of standards and appropriately diluted samples 
were placed in clean, dry test tubes and 0.8 ml of buffer 
was placed in a blank tube. Biorad reagent concentrate 
(0.2 ml) was then placed into the test tubes and the 
solutions were mixed by inversion taking care to avoid 
excess foaming. 
After a period of i hour the absorbances were measured 
at 595 nm against reagent blank. A plot of absorbance 595 
rim versus standards then meant that unknowns could be read 
from the standard curve. Figure 17 shows two graphs of 
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